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The horseshoe crab, Carcinoscorpius rotundicauda, possesses a powerful innate 
immune system capable of clearing Gram-negative bacteria (GNB) infections at dosages 
that would be lethal to mice. Rapid bacterial neutralization and clearance suggests the 
existence of extracellular frontline defense molecules that effectively recognize 
lipopolysaccharide (LPS). C-reactive protein (CRP)-1 and -2 are major extracellular 
defense lectins that bind LPS. In contrast to a single CRP gene in humans, horseshoe 
crabs possess numerous CRP genes, grouped into three isotypes based on sequence 
homology and biochemical characterizations. The nature of CRP heterogeneity and the 
roles of different isoforms remain unclear. This study aims to elucidate the roles of CRP-
1 and -2 during GNB infection and to verify functional differences between them.  
Functional segregation of CRPs may be attributable to their different interaction 
partners. Glutathione S-transferase (GST) -pull down experiments suggest that both 
recombinant rCRPs interact with different plasma proteins. rCRP-1 interacts 
preferentially with galactose-binding protein (GBP), while rCRP-2 oligomerise with 
other CRP isoforms and interacts with carcinolectins (CLs), which are homolougous to 
tachylectins (TLs) found in the Japanese horseshoe crab. The different interaction 
partners of CRP-1 and -2 suggest they mediate different pathways in immune responses.  
rCRP-1 and -2 interact with proteins of the naïve cell-free hemolymph (CFH). 
This naïve CRP-complex represents a pool of innate immune molecules that readily 
associate into a “pathogen-recognition complex” early in infection. The interactions of 
both rCRP-1 and -2 are enhanced during infection and in the presence of calcium. 
Calcium-dependent interaction of human CRP (hCRP) with phosphorylcholine is well 
 x
known and has been the main paradigm of CRP biochemical characterization. In contrast, 
the interaction of CRPs with other innate immune molecules has not been documented. 
Observation of enhancement CRP interactions during infection is also novel and suggests 
that CRPs mediate post-infection physiology. Recently, hCRP was reported to show 
diverse glycosylation patterns upon infection (Das et al, 2003). Pull down experiments 
show that glycosylation enhances the interactions between CRPs and other plasma 
proteins. This suggests that glycosylation of hCRP primes it for recruitment of a similar 
“pathogen-recognition complex” that is important for immune function during pathogen 
challenge.    
 CRP-2 exhibits bacterial agglutination and bactericidal activities. Specifically, it 
exerts its effects via interactions with the phosphorylethanolamine (PEA) and Lipid A 
motifs of LPS. Neither glycosylation nor calcium enhanced bactericidal activity, 
suggesting that these factors are not necessary for the antimicrobial properties of CRP but 
are important for recruitment of the “pathogen-recognition complex”, which 
consequently mediates bacterial clearance via other antimicrobial mechanisms. This is 
corroborated by our observation that the “pathogen-recognition complex” mediated more 
rapid bacterial clearance than just CRP-2 alone.  
 (429 words) 
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INTRODUCTION 
1.1 The horseshoe crab—a living fossil 
Horseshoe crabs are evolutionarily ancient organisms and are considered “living 
fossils”. Since their first appearance in the early Paleozoic these animals have remained 
largely unchanged and have, in fact, survived two mass extinction events over the past 
400 million years (Stormer, 1952). 
 Anatomy— Horseshoe crabs derive their name from the fact that their carapace 
resembles that of a horse’s hoof. They have a dorsal surface shielded by a large anterior 
carapace. This extends backwards to cover the periphery of the posterior abdominal 
carapace (Barnes, 1987). Under this dome-like structure, the soft body parts are 
protected. The body proper consists of a pair of tri-segmented chelicerae and five pairs 
of legs that border the anterior margin of the abdomen in the cephalothorax (Barnes, 
1987). The posterior end of the horseshoe crab is punctuated by a spike-like telson 
(Barnes, 1987). This is used by the horseshoe crab to right itself should it be flipped 
over (Ng & Sivasothi, 1999). 
Taxonomy and Distribution--All horseshoe crabs are members of the phylum 
Arthropoda, which includes crabs, insects, scorpions and spiders. Their name is in fact 
a mis-nomer, as horseshoe crabs belong to the subphylum Chelicerata and are more 
closely related to the spiders. Horseshoe crabs are, literally, in a class of their own, the 
Merostomata (Barnes, 1987), which describes aquatic chelicerates. All four extant 
members are of the subclass Xiphosura (Barnes, 1987) and are scattered around the 
globe. The American horseshoe crab, Limulus polyphemus, is distributed along the 
Atlantic coast and the Gulf of Mexico. The Japanese horseshoe crab, Tachypleus 
tridentatus, is scattered around the islands of Japan and the Korean peninsular (Botton, 
2001). While in South-east Asia, both Tachypleus gigas and the Singapore horseshoe 
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crab, Carcinoscorpius rotundicauda, inhabit the coast and the mangroves and marshes 
of the region. Both T. gigas and C. rotundicauda are found along Singapore’s northern 
shoreline. In particular, C. rotundicauda is found around the Kranji estuary facing the 
Johor Straits, in the north of the main island of Singapore.  
1.2 The challenge of a pathogen-laden environment 
In Singapore, where space is scarce and land use pressures are intense, the land-
sea margin is frequently exploited for development (Savage, 2001), leaving only tiny 
pockets of natural estuarine habitats. In the marshy grounds of the Kranji estuary, 
industrial development threatens to encroach upon the horseshoe crabs’ niche. During 
the course of obtaining specimens, direct discharge of industrial waste into estuarine 
waters has been observed. Tidal patterns have also deposited large amounts of waste 
materials around the area. Much of this material is biodegradable and possibly carries 
high bacterial loads. 
The burrowing habits of the horseshoe crabs also cause them to come into 
further contact with large numbers of microorganisms. While no attempt has been made 
to quantitate the bacterial load in local mangroves, Austin (1988) has estimated that 
bacterial populations in seawater range from 103 to 106 colony forming units (cfu)/ mL. 
Closer to shore and in areas of highly organic sediment, counts of more than 109 cfu/ g 
have been recorded (Austin, 1988). That the horseshoe crab is able to tolerate 
conditions with such large numbers of microbial populations suggests it possesses a 
highly sensitive and fast-acting immune system that allows it to preserve its integrity 
amidst a variety of environmental insults. 
1.2.1 Horseshoe crabs have a robust innate immune system 
Like other invertebrates, horseshoe crabs are unable to mount adaptive immune 
responses and, instead, rely on various defense systems that distinguish non-self from 
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self. These respond to common surface antigen present on pathogens and are 
collectively termed the “innate immune system” (Medzhitov, 2000). This strategy has 
not been detrimental; in fact, the predominant resistance mechanisms operative during 
early phases of infections do not require antibody-mediated processes (Scherer & 
Miller, 2001).  
Innate immune responses—triggered by non-clonal cells bearing germ line-
encoded recognition receptors—are operative during initial stages of infection. Acute-
phase pattern recognition receptors (PRRs) are produced to bind a variety of pathogen-
associated molecular patterns (PAMPs). In addition, many invertebrates activate 
inducible cellular and humoral defenses following stimulation with bacterial products. 
For example, hemolymph coagulation, prophenoxidase-mediated melanization and host 
cell agglutination  (Aderen et al, 2000; Imler et al, 2000; Pieters, 2001) are induced 
directly by lipopolysaccharide (LPS) of gram negative bacteria, lipotechioic acid (LTA) 
of gram positive bacteria and/ or (1,3)-β-D-glucan, which is found on fungal cell walls. 
The resulting activation of the complement and coagulation cascades, as well as 
opsonization, phagocytosis and apoptosis by host cells (Janeway & Medzhitov, 2002; 
Underhill & Ozinsky, 2002), all serve to isolate and remove the offending invader. In a 
healthy host, innate immune mechanisms on their own are sufficient to combat most 
pathogens and adaptive responses become unnecessary (Janeway & Medzhitov, 2002). 
The fact that invertebrates are the most evolutionarily successful phylum speaks for the 
success of innate immunity.  
 Horseshoe crabs, in particular, appear to have utilized innate immune 
mechanisms most successfully. In our lab, infection studies on the Singapore horseshoe 
crab, Carcinoscorpius rotundicauda, have demonstrated that106 cfu of Pseudomonas 
aeruginosa was rapidly suppressed. Such a dosage would have been lethal to mice, but 
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horseshoe crabs are able to completely clear the infection within 3 days (Ng et al, 2004). 
Such a robust innate immune system may be one of the key reasons for the 





FIG 1.1: The pathogen-laden environment of the horseshoe crab. (A) The 




pathogen-laden environment in the marshes off Kranji estuary but is able to maintain its 
integrity in the midst of high pathogen loads. 
1.2.2 Elements of the horseshoe crab innate immunity 
Innate immune molecules are present in both the cellular and humoral systems 
of the horseshoe crab. Granular hemocytes comprise of 99% of the circulating blood 
cells in the horseshoe crab. The large (L)-granules of these cells selectively store more 
than 20 innate immune molecules. Many of these function chiefly in hemolymph 
coagulation. In contrast, the small-granular structures (S-granules) sequester only five 
proteins, all of which demonstrate activities against bacteria and fungi (Toh et al, 1991). 
All these cells are highly sensitive to LPS, and respond to its presence by degranulating 
the hemocytes, so releasing large numbers of defense molecules. Acting together, these 
form a highly complex and sophisticated innate immune system to defend the organism 
from invading microbes.  
Amongst the many innate immune mechanisms in invertebrates, hemolymph 
coagulation has been intensively studied and is well-understood. Hemolymph 
coagulation was first discovered in 1956, when Frederik Bang first described fatal 
intravascular coagulation in L. polyphemus that was caused by the endotoxin of a 
pathogentic Vibrio species. Levin (1968) subsequently showed that this coagulation 
resulted from enzymatic conversion of a clottable protein. Proteins participating in 
coagulation are derived from large granules of circulating hemocytes (Toh et al, 1991). 
Specifically, Factor C, a serine protease zymogen, acts as a LPS-biosensor and induces 
autocatalytic activation of itself. This in turn activates Factor B, which then converts a 
proclotting enzyme to its active form for blood coagulation. The conversion of 
coagulogen into coagulin results from the polymerization of noncovalently bound 
coagulin in a “head-to-tail” orientation (Osaki et al, 2004). Conversion of the 
preclotting enzyme is also achieved by Factor G, a sensor of β-1,3-glucan, a PAMP  
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found on fungal cell walls. Today, the Limulus amoebocyte lysate (LAL) is recognized 
as a potent detector of LPS and forms the basis of the LAL assay, a test commonly 
employed to check for contaminating pyrogens in a clinical environment (Iwanaga et al, 
1997). The LAL used to make endotoxin detectors is traditionally taken from wild 
horseshoe crab populations. As a result of intensive bio-prospecting, Limulus 
populations have declined rapidly (Widener & Barlow, 1999) and the species is now 
classified as a near-threatened species (http://www.redlist.org/). 
Aside from components of coagulation cascade, another major group of proteins 
present in the hemocytes are lectins. Lectins may be simply defined as proteins which 
bind carbohydrates, although much about their physiological functions remain unclear. 
A feature of lectin binding is its low affinity (mM range) for a single monosaccharide 
residue and/ or its derivative. However, avidity for the ligand is dramatically increased 
via oligomerization of the lectins to form multiple binding sites for carbohydrates, 
which are themselves multivalent ligands (Loris, 2002). Multivalency is not an absolute 
requirement for all lectins, but appears to be an important factor for most (Loris, 2002). 
Four lectins have been found in hemocytes of the Japanese horseshoe crab, designated 
tachylectin (TL)-1 to 4. These exhibit different carbohydrate specificities and are PRRs 
that probably bind different moieties of conserved PAMPs. For example, TL-1 binds 
KDO whilst TL-3 binds the O-antigenic region of LPS, a Gram-negative bacterial 
PAMP. Unfortunately, biochemical characterizations of these lectins do not shed light 
on their real-time collaborative responses following in vivo infection.   
The cell-free component of the hemolymph of the horseshoe crab is also known 
to contain a range of molecules highly sensitive to insults by pathogens and foreign 
materials (Iwanaga et al, 1997). In particular, the circulating hemolymph consists of 
three principal proteins: hemocyanin, α2-macroglobulin (α2m) and C-reactive protein 
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(CRP). Hemocyanin functions principally as an oxygen carrier, analogous to the 
function of hemoglobin in mammals. α2m is conserved in mammals and is also present 
in the plasma of many invertebrates. In the American horseshoe crab, Limulus 
polyphemus, α2m is the only protease inhibitor present in the plasma. Melchior and co-
workers (1995) have demonstrated that α2m binds active proteases, which are then 
cleared from the plasma via a receptor-mediated endocytotic process. Further, α2m is 
structurally related to the γ-chain of the human C8 complement factor and is thought to 
be involved in the complement cascade (Iwanaga et al, 1997). Like the other TLs, CRP 
is a lectin PRR and is found in the plasma of both Carsionoscorpius (Ng et al, 2004) 
and Limulus (Roby & Liu, 1981). Additionally, Tachypleus also possess a plasma lectin, 
TL-5. This protein exhibits broad specificity for substances containing the N-acetyl 
moiety and demonstrates the strongest bacterial agglutinating activity among the all 
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from Limulus polyphemus. Roby & Liu, 
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TABLE 1.1: Some innate immune defense molecules that may be found in the 
hemocytes and hemolymph of the horseshoe crabs. These have been grouped 
functionally according to their activities and their locations. The small (S)-granules of 
the hemocytes contain about 5 proteins that act against a wide range of pathogens. In 
constrast, large (L)-granules are though to contain more than 20 innate immune defense 
molecules. These include components of the coagulation cascade and a range of lectins.  



















1.2.3 Plasma lectins are key components in frontline immune defense 
Rapid bacterial clearance is dependent upon the action of fast-acting innate 
immune molecules. The route of infection for many pathogens involve crossing the 
blood barrier whilst systemic infection is characterized by invasion of pathogens into 
the plasma. Owing to their extracellular location, plasma lectins that recognize PAMPs 
represent frontline pattern recognition receptors (PRRs) that are involved in 
immunosurveillance and thus play a pivotal role in halting and neutralizing pathogen 
invasion.  
The importance of plasma lectins is further exemplified by their evolutionary 
conservation. Fibrinogen domain-containing lectins such as ficolins (Lu et al, 2002) 
and TLs-5 (Gokudan et al, 1999) are found in invertebrates like the horseshoe crab, 
while C-type lectins such as immunolectins (Volanakis, 2001) and collectins (Lu et al, 
2002) are found in the tobacco horn worm and in mammals. C-reactive protein (CRP) 
is even more prevalent, existing in many vertebrates and invertebrates (Iwaki et al, 
1999). 
Responses downstream to PAMP-recognition by plasma lectins such as 
mannose-binding lectin (MBL), ficolin (Lu et al, 2002) and CRP (Volanakis, 2001) 
include pathogen opsonization and complement cascade activation.  In the horseshoe 
crab, PAMP-recognition by TLs-5 (Gokudan et al, 1999) triggers agglutination of a 
wide range of bacteria, leading to speculation of an opsonization function. While the 
triggering of overlapping downstream responses by a range of serum lectins appears to 
suggest a redundancy of function of PRR lectins, clinical manifestations of MBL 
deficiency (Kilpatrick, 2002) implies that each lectin contributes differently and 
significantly towards achieving the full potential of the innate immune system.   
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1.3 The role of C-reactive proteins in frontline immune defense 
1.3.1 Human CRP - a versatile diagnostic and prognostic marker 
One lectin thought to play an essential role in innate immunity is the C-reactive 
protein (CRP). CRP was first identified in human serum in1930, as a co-precipitate of 
the C-polysaccharide cell wall of Streptococcus pneumoniae.   The calcium-dependent 
interaction of CRP with the phosphorylcholine (PC) moiety (present in C-
polysaccharide) has been the main paradigm for CRP characterization (Kaplan et al, 
1977). X-ray crystal structures indicate that CRP oligomerizes as a pentameric protein 
with each subunit tipped towards the central fivefold axis. PC is bound in a shallow 
pocket on the surface of each subunit and appears to interact with the two protein-
bound calcium ions via the phosphate group (Thompson et al, 1998).  
Like homologues found in invertebrates, human CRP (hCRP) plays a pivotal 
and complex role in the immune response. hCRP is the classical acute-phase reactant 
produced in response to tissue damage and inflammation (Gewurz et al, 1982; Gewurz 
et al, 1995; Volanakis, 1982). CRP protein levels rise 42-684- fold above basal levels 
under different pathological stresses (Black et al, 2004). Because of its predictable 
behavior CRP has gained clinical utility and CRP levels have become important clinical 
prognostic tools for a wide range of human diseases. CRP levels have been correlated 
to insulin resistance, metabolic syndrome, atherosclerosis (Lee et al, 2004), rheumatoid 
arthritis (Nielen et al, 2004) and renal failure (Ortega et al, 2004). Despite such 
extensive use of CRP levels to judge disease susceptibility and progression, the actual 
involvement of CRP in the pathophysiological presentation of diseases is unknown.  
Overall, the evolutionary conservation of CRP across phyla suggests that CRP 
possesses roles that are indispensable for survival.  In addition, there are no living 
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individuals with CRP deficiency, suggesting that an apparent lethal condition can result 
from the lack of just this one lectin type. All these evidences point to the fundamental 
role of CRP in human innate immunity. 
1.3.2 Gram-negative septicaemia is a widespread medical problem 
Inflammation is a cytokine-regulated process that is both an integral part of the 
normal immune reaction, as well as a detrimental bodily function. Bacterial, fungal, 
viral or parasitic infestations all result in induction of the inflammatory network. When 
production of pro-inflammatory molecules is pushed beyond physiologically tolerable 
levels, the balance of cytokine-induced inflammatory responses is tipped and 
septicaemia ensues (Oberholzer et al, 2000). The clinical pattern of this acute 
inflammation is termed systemic inflammatory response syndrome (SIRS) and is 
characterized by irregular haemodynamics, coagulatory malfunctions and leukocyte-
induced tissue injury (Karima et al, 1999) As sepsis progresses, low perfusion of the 
peripheral circulation and other organs occurs, leading to cell death by tissue anoxia, 
finally resulting in organ failure, which is the main cause of mortality. (Karima et al, 
1999; Brady & Otto, 2001).  Clearly, the consequences of pathogen invasions are grave 
when not managed properly.  
Infections by Gram-negative bacteria (GNB) are the predominant cause of 
clinical sepsis (Bone, 1996). Within the United States, 300,000 to 500,000 cases of 
septicaemia occur annually, with mortality rates ranging from 20% to 40% (Dellinger 
et al, 1997). According to the Centre for Disease Control and Prevention (CDC), 
Atlanta, septicaemia and septic shock represent the thirteenth leading cause of death in 
the United States and is estimated to incur up to US$10 billion worth of economic loss 
(as quoted by Wenzel et al, 1995).  
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Amongst the many GNBs responsible for septicaemia, Pseudomonas 
aeruginosa is a leading causative agent (Wenzel et al, 1995). P. aeruginosa is a 
ubiquitous GNB noted for its environmental versatility and its resistance to a range of 
antibiotics. The bacterium is capable of utilizing a wide range of organic compounds as 
food source, thus giving it an exceptional ability to colonize unusual ecological niches 
where nutrients are limited (Clarke, 1990). Additionally, P. aeruginosa produces a 
number of proteins that cause extensive tissue damage and interfere with human 
immune defense mechanisms. These range from potent toxins that kill host cells at or 
near the site of colonization, to enzymes that disrupt cellular membranes and 
connective tissues in various organs (Clarke, 1990). Despite its versatility, P. 
aeruginosa is an opportunistic pathogen that only causes clinical manifestations of 
disease in susceptible hosts (Clarke, 1990). Within a clinical environment, 
immunocompromised patients, such as cancer patients and burn victims commonly 
suffer serious infections by this organism, as do other individuals with immune system 
deficiencies. Given the prevalence of sepsis worldwide and the pervasiveness of P. 
aeruginosa in causing sepsis, this particular bacterial species is an important target for 
study. 
During GNB infections, detection of LPS, a pathogen-associated molecular 
pattern (PAMP) anchored on the outer wall of the bacteria, triggers a series of 
physiological responses. Some of these enhance the inflammatory response, while 
others serve to neutralize endotoxic effects (Karima et al, 1999).  The interaction of 
LPS with the myeloid cell surface antigen, CD14, has been well characterized and is 
known to be pivotal in mediating LPS-dependent signal transduction into macrophages. 
The binding of LPS to glycosylphosphatidylinositol-anchored CD14 is facilitated by 
lipopolysaccharide-binding protein (LBP), an acute phase serum component (Wright et 
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al, 1990).The binding of the LPS-LBP complex to membrane-bound CD14 triggers a 
cell signaling pathway, whose mechanisms are not been fully understood (Ingalls et al, 
2000; Medvedev et al, 2001). The end result is increased biosynthesis of both pro-and 
anti-inflammatory cytokines such as interleukin and TNF-α (Ulevitch & Tobias, 1995). 
The LBP-LPS complex has also been found to associate with soluble CD14 (sCD14). 
Elevated levels of sCD14 are associated with inflammatory infectious diseases and high 
mortality in Gram-negative septicaemia (LeVan et al, 2001) and LBP-LP-sCD14 can 
trigger non CD14-possessing cell types such as endothelial. The presence of endotoxin 
also activates the humoral arm of the immune system. Endotoxin activates the 
complement cascade, which fuels the inflammatory response, and the coagulation 
cascade, which results in disseminated intravascular coagulation (Glauser et al, 1991). 
Live GNBs also release peptidoglycans, muramyl peptides and other as-yet unidentified 
substances that induce cytokine secretions (Murphy et al, 1998). Despite attempts at 
ameliorating the effects of sepsis by novel applications of cytokine antagonists (Wenzel, 
1991), alternatives to antibiotics remain elusive. Further, the arsenal of antibiotics 
available to treat bacterial infection becomes more limited due to the problem of 
antibiotic resistance (Hall & Collis, 2001).  Overall, septicaemia is a multifaceted 
process involving multiple self-propagating and interconnected cascades. The 
complexity of the pathogenesis of septicemia remains the greatest obstacle to its 







FIG 1.2: The consequence of sepsis include over production of cytokines and 
uncontrolled inflammation, leading to circulatory malfunctions, shock and multiple 
organ failure. Adapted from Oberholzer et al, 2000. 
  
1.3.3 LPS: ubiquitous, persistent and versatile molecules 
As discussed above, GNBs are largely responsible for the prevalence of 
septicaemia in clinical settings. The key to the primacy of GNBs in causing sepsis is its 
PAMP, lippopolysaccharide (LPS). LPS form a class of macromolecules unique to 
GNB (FIG 1.3). These are PAMPs located on the outer membrane of GNB and are 
referred to as endotoxins because of their pyrogenic (fever-causing) properties in 
humans and other mammals (Opal & Gluck, 2003).  Structural analysis indicates that 
GNBs depend on endotoxin for protection against external assaults. Endotoxin is 
arranged so that the more hydrophilic polysaccharide chains face away from the 
membrane while the hydrophobic fatty acyl chains of Lipid A are anchored in the 
bacterial membrane. Lipid A is tilted at an angle greater than 45˚ at the membrane 
interface (Seydel et al, 2000). Such an arrangement effectively packs columns of fatty 
acid tightly against one another and confers a “sealed armour” to the bacteria. An 
additional layer of polysaccharides around the membrane forms an additional protective 
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barrier to GNB (Rietschel & Brade, 1992). Consistent with the idea that a monolayer of 
LPS covers a single GNB, the envelope of a single E. coli cell contains ~2 x 106 LPS 
molecules (approximately 20 femtograms) of LPS. This estimate is deceptive; a modest 
bacterial load of 1 x106 CFU of E. coli would contain 20 µg of LPS and represents an 
amount that is 10,000-fold the lethal dosage in mice. (Tan et al, 2000). 
Adding to problem of abundance, endotoxins are highly resilient molecules. 
They are thermostable and remain largely unaffected by changes in pH. 
Depyrogenation requires either high concentrations of acids or bases, or high heat of 
200˚C for at least 2 h (Minabe et al, 1994).    
Not all LPS are created equal. In particular, the polysaccharide chain of LPS is 
highly variable. When a population of wild strain of bacterium is irradiated with UV 
light or exposed to mutagenic compounds, those mutations that are not lethal give rise 
to several rough (R) strains which are not generally found in nature and which possess 
unique characteristics. Often, the genes which encode lipopolysaccharide formation are 
altered and results in shorter polysaccharide chains. The mutants are designated Ra, Rb, 
Rc, Rd and Re, where a, b, c and so on indicate different points along the 
polysaccharide chain which may be cleaved (FIG 1.3B). Ra and Re thus represent 
mutants with the longest and shortest chain lengths respectively (Raetz, 1990). The 
most extreme are the Re mutants, which produce LPS made up solely of Lipid A and a 
2-keto-3-deoxyoctonate (KDO) core. Although compact in size and structure, these 
LPS chemotypes are by no means limited in their endotoxic activity; LPS prepared 
from Salmonella minnesota Re 595 mutants has been shown to induce secretion and 
aggregation of human platelets (Gardiner et al, 1991).Re mutant LPS may thus be 







FIG 1.3: LPS is a Gram-negative bacterial PAMP. (A) Molecular organization of 
the envelope of Escherichia coli K-12. Ovals and rectangles represent carbohydrate 
residues, as indicated. Circles represent the polar head groups of glycerophospholipids 
(dark gray ovals, glucosamine derivatives; blue ovals, N-acetylmuramic acid; yellow 
rectangles, L-rhamnose; orange ovals, D-galactofuranose; red circles, ethanolamine-
phosphate; green circles, glycerol-phosphate). Abbreviations: Kdo, 3-deoxy-D-manno-
octulosonic acid; LPS, lipopolysaccharide; MDO, membrane-derived oligosaccharides. 
Adapted from Wyckoff et al (1998). (B) The chemical structure of LPS with its 
constitutents.  Salmonella minnesota Re 595 LPS consists of Lipid A and a KDO core. 





1.3.4 CRP: role in bacteria neutralization? 
In our lab, attempts to identify LPS-binding proteins from the cell-free 
hemolymph of the horseshoe crab have led to the isolation of C-reactive protein 
isotypes 1 and 2 (CRP-1 and -2) as the major eluant from a LPS-affinity column (Ng et 
al, 2004), confirming the biochemical affinity of this protein to this PAMP. Using the 
horseshoe crab as a model for infection studies, our lab has also demonstrated that CRP 
was rapidly depleted during the first hour of challenge with Pseudomonas aeruginosa. 
Transcriptional activity of CRP genes increased markedly and the extracellular pool of 
CRP was replenished by 6 h post-infection (hpi). These results suggest that (1) CRP a 
critical frontline immune defense molecule that exists as a large pre-existing pool, 
ready to bind LPS and mediate innate immune responses upon contact with Gram-
negative bacteria, (2) CRP levels are maintained at high levels by transcriptional 
homeostatic mechanisms, and (3) this transcriptional activity is regulated by signaling 
pathways that are initiated by infection CRP (Ng et al, manuscript in 
preparation).These results are in agreement with those of human CRP, which is a 
classical acute-phase protein that is known to be markedly upregulated during infection 
(Black et al, 2004). The ability of CRP to bind LPS suggests that it plays a role in 
neutralizing the lethal effects of Gram-negative bacteria and possibly limit the 
development of sepsis. Several lines of evidence support this hypothesis with regards to 
human CRPs. 
In vitro, human CRP (hCRP) binds phosphorylcholine (PC) and its associated 
microbes. Aside from S. pneumoniae, PC has been identified on other Gram-positive 
bacteria including Clostridium, Lactococcus and Bacillus (Gillespie et al, 1996), as 
well as on the Gram-negative bacteria Haemophilus influenza, Neisseria meningitides, 
and N. gonorrhoeae (Kolberg et al, 1997). Despite the possible different array patterns 
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of PC on these pathogens, hCRP can bind with high avidity because of the pentameric 
arrangement of its binding sites (Thompson et al, 1998). The complement 
subcomponent C1q is then able to dock onto ligand-bound CRP (Mold et al, 1999) and 
results in the serial activation of C1r (enzyme), C1s (proenzyme) and the other 8 
components of complement (Gilmour et al, 1980). Complement activation promotes 
both the deposition of C3b onto the CRP/ ligand complex, and the subsequent 
recognition of the complex by complement receptors on phagocytes. hCRP thus 
enhances opsonization and phagocytosis of microbes. The protective effects of hCRP 
are not limited to bacteria. hCRP binds to both Aspergillus and Candida albicans 
(Richardson et al, 1991 A & B) and promotes their complement-independent 
phagocytosis by human leukocytes. 
In vivo, pretreatment with human CRP has been demonstrated to increase the 
survivability of mice subsequently infected with S. pneumoniae (Mold et al, 1981). 
Murine CRP is not an acute-phase reactant and it is only synthesized in trace amounts. 
The mouse model thus serves as a convenient tool for the studying protective effects of 
CRP. More recently, transgenic mice expressing human CRP demonstrated increased 
survival time and survival rates following challenge with S. pneumoniae and S. enterica. 
The greater resistance of transgenic CRP mice could be attributed to early clearance of 
pathogens from the blood and significantly decreased numbers of bacteria in the liver 
and spleen 7-days post-infection (Ciliberto et al, 1987). 
Taken together, the demonstrations that hCRP exhibits affinity for LPS, binds 
microbes, mediates their killing in vitro and protects against Gram-positive and Gram-
negative bacteria in transgenic CRP mice all support the notion that hCRP plays an 
important role in host defense and in neutralizing bacteria. These functions are 
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activated via ligand-binding sites on one face of the hCRP pentamer, and C1q-binding 
sites on the other.  
 
FIG 1.4: Human CRP is an important immune defense molecule. It has the ability 
to mediate pathogen-binding and complement activation.  
 
1.3.5 In vivo functions of CRP remain enigmatic 
While only a single CRP gene has been isolated in human, horseshoe crabs 
exhibit significant CRP polymorphisms. Unlike human CRP, functions of these 
isoforms are less well-defined.     
Three types of CRPs have been identified in the Japanese horseshoe crab, 
Tachypleus tridentatus. These CRPs are named T. tridentatus CRP (tCRP)-1, tCRP-2 
and tCRP-3, and each consists of several isoforms. These exhibit differential binding 
affinity to various carbohydrate moieties, and have different hemolytic and 
haemagglutination profiles.  Of the three CRPs, tCRP-1 is the most abundant isotype 
and binds to phosphorylethanolamine (PEA), but lacks both hemolytic and sialic-acid-
binding activities. In contrast, tCRP-3 represents a novel class of hemolytic CRP which 
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lacks binding affinity for PEA. tCRP-2 exhibits affinity for colominic acid (polysialic 
acid), a bacterial PAMP and is capable of eliciting hemolysis . Interestingly, tCRP-2 
had previously been shown to agglutinate human erythrocytes and E. coli K1 strain, but 
has not been definitively demonstrated to exhibit antibacterial activity. Moreover, all 
three CRP isotypes from Tachypleus were differentiated on the basis of biochemical 
affinities and, in fact, consist of mixtures of isoprotein (Iwaki et al, 1999). The activity 
of individual CRP isoforms has thus not been definitively elucidated.   
Similarly, two homologues of CRP have been found in the Atlantic horseshoe 
crab, Limulus polyphemus (Robey & Liu, 1981; Kaplan et al, 1977). Limulus CRP is an 
abundant pentraxin lacking sialic-acid-binding and hemagglutinating activities, 
although it binds PEA. In constrast, limulin, another lectin in the plasma, exhibits 
sialic-acid- and PEt-binding activity (Quigley et al, 1994). Armstrong and coworkers 
(1996) have also demonstrated that limulin is the mediator of the Ca2+-dependent 
hemolytic activity in the Limulus plasma. 
While these biochemical characterizations provide clues as to interactions of 
CRPs, their actual in vivo role(s) remains unclear, as no attempt has been made to 
delineate the functional overlaps amongst CRP isotypes. And while recent research has 
emphasized the importance of synergistic and dynamic protein networks in various 
physiological systems, information on real-time collaborative responses of lectins in 
vivo following infection is lacking. The collaborative response of CRPs—amongst 






1.4 Objectives and scope of the project 
Various attempts have been made to map LPS-induced signal transduction 
events in totality using high throughput tools (Dax et al, 1998), with each method 
focusing on different levels of gene expression involved in the pathway. This project, 
however, aims to study innate immune defense, not at the genomic level, but directly 
targets protein activity in response to pathogen challenge.  
While previous studies have demonstrated the antimicrobial properties of the 
blood plasma of Carcinoscorpius rotundicauda (Kim, 1992; Yeo et al, 1993), much is 
still unknown as to the frontline innate immune molecules that recognize LPS of Gram-
negative bacteria.  
As our lab had recently identified CRP-1 and -2 as the major proteins binding 
LPS( Ng et al, 2004), it is speculated that these might mediate the detection of 
pathogens in hemolymph as well as the downstream activation of other plasma defense 
molecules. In seeking to map CRP diversity in the horseshoe crab, our lab has 
identified several isoforms of CRP-1 and -2 by 5’ and 3’RACE, several of which 
exhibited silent mutations.  The differential affinities of the major CRP isotypes to 
various ligands possibly indicate functional differences. Individual isoforms, on the 
other hand, might differ from one another in terms of functional efficiency.  
This project will concentrate on the functional characterizations of the one 
CRP-1 isoform that exhibits no silent mutations, and the most abundant CRP-2 isoform. 
Using these as models of the two CRP isotypes, we aim to clarify the interactions of 
CRP-1 and -2 with protein partners in the cell-free hemolymph (CFH) and to map 
general functional overlaps and/ or divergences between the two isotypes of CRPs.  
Current understanding about the antimicrobial properties of CRP requires 
interactions with the complement and humoral arms of the immune system. The action 
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of Tachypleus CRP-2 on E. coli, however, appears independent of other innate immune 
components. As an extension of CRP-2 characterizaion, this project will also 
investigate and propose possible mechanisms for the antimicrobial activity of 
CRP-2.  
Understanding functions of the CRP repertoire in an evolutionary ancient 
organism such as the horseshoe crab would help shed light on the pathophysiological 
role of CRP in humans.   
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MATERIALS and METHODS 
All materials used were rendered pyrogen-free. Glassware and salts that are heat-
stable were baked at 200°C for 4h (Minabe et al, 1994). Whenever possible, sterile plastic 
disposables were used. Non-disposable plastic wares were rinsed thoroughly with pyrogen-
free water (Baxter) and autoclaved for 121°C for 15 min. All chemicals used were 
commercially-obtained reagent-grade and used without further purification. Solutions and 
buffers were prepared using pyrogen-free water. LPS or lipid A suspensions were sonicated 
for 5 min in a 37°C water bath to monodisperse the aggregates prior to use. Endotoxins were 
contained in borosilicate glassware to minimize loss by absorption to containers (Novitsky et 
al, 1986).   
2.1 Collection of horseshoe crab hemolymph 
Horseshoe crabs, Carcinoscorpius rotundicauda, were collected from the estuary of 
the Kranji River, Singapore.  These were washed to removed mud and debris and were 
acclimatized overnight in minimal levels of 30% sea water. 
Hemolymph was obtained by cardiac puncture. The carapace around the vicinity of the 
cardiac chamber was washed with detergent and swabbed with 70 % ethanol. The crabs were 
then partially bled by inserting a sterile needle (18 gauge; Becton Dickinson™) between the 
two plates of the dorsal carapace in a posterior direction, so puncturing the cardiac chamber 
(FIG 2.1). Differences in ambient pressure and the hemolymph caused blood to be naturally 
ejected. The time taken for equilibration of pressure usually allowed an average volume of 10 
mL to be collected. Hemolymph was collected into pre-chilled, pyrogen-free centrifuge tubes 
and was clarified from hemocytes by centrifugation at 150 x g for 15 min at 4 ºC. Cell debris, 
contaminants and excess hemocyanin were removed by further centrifugation at 9,000 x g for 
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10 min at 4°C. PMSF was added to the cell-free hemolymph to a final concentration of 1 mM.  
The hemolymph was then quick-frozen in liquid nitrogen and stored at -80 °C.   
For infection by P. aeruginosa, 106 cfu of bacteria was resuspended in 200 µl of 0.9% 
saline and was injected intracardially.  At 1 hour post-infection (hpi), infected hemolymph 
was collected and processed as described above. The use of 106 cfu P. aeruginosa cultures 
was derived from previous studies in the lab to determine lethal dosage and time course of 
action of the bacteria to the horseshoe crab sample population. Briefly, it was observed that 
dosages of >108 caused death in all treated individuals within 48 hours. Within the first 3 h 
after inoculation with dosages of 105 cfu or more, P. aeruginosa was rapidly cleared from the 
hemolymph of the individuals tested. A dose of 106 cfu was thus determined to be optimum 
for induction. This was a sub-lethal dosage, yet potent enough to elicit a rapid response so 
innate immune molecules that reacted most acutely to LPS were produced after 1 h, when 
induced hemolymph was sampled. Moreover, sampling hemolymph after such a short period 
of bacterial challenge would most likely identify acute-phase innate immune molecules. 
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FIG 2.1: Collection of horseshoe crab hemolymph. CFH was obtained by cardiac puncture. 
 
2.2 Cloning CrCRPs  
Following identification of CRP isoforms as the major LPS-binding protein in the cell-
free hemolymph of the horseshoe crab, 5’ and 3’ RACE was carried out, using degenerate 
primers derived from the Q-TOF sequence of CRP (Ng et al, 2004). Populations of clones 
harbouring the 5’ and 3’ RACE fragments of CrCRP-1 and -2 were digested with NdeI (New 
England Biolabs) at 37˚C for 3hr. The digested DNA species were subjected to agarose gel 
electrophoresis to ascertain the efficiency of digestion.  
Correctly digested DNA was extracted using the Qiagen gel extraction kit. 3’ RACE 
fragments were then ligated to the appropriate linearised pGEM-T Easy plasmids, harbouring 
the 5’ RACE fragments, using T4 DNA ligase (Roche). Cloned pGEM-T Easy plasmids with 
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full-length CRP ORFs were used as templates for cloning CrCRP-1 and -2 into bacterial and 
yeast expression vectors, pGEX-4T-3 (Amersham) and pYEX-4T-3 (Clonetech) respectively. 
pGEX and pYEX may be considered “sister” plasmids. Both encode a GST gene 
derived from the parasitic helminth, Schistosoma japonicum, immediately upstream of the 
multiple cloning site (MCS). The arrangement of restriction sites within the MCS is similar 
for both plasmids. A single pair of primers incorporating enzymatic cut sites is thus sufficient 
to clone CrCRP-2 into both vectors. Both pGEX and pYEX contain the E. coli Ampr gene. 
Both species of cloned plasmids may then be propagated in E. coli, with ampicilin as the 
selecting agent. pYEX also contains the yeast selectable markers leu2-d (a LEU2 gene with a 
truncated but functional promoter) and URA3 and is thus a dual-host vector. In both vectors, 
there is a cleavage site for the protease, thrombin, between the GST coding region and the 
MCS. The GST-tag facilitates affinity purification of the resultant recombinant fusion protein, 
while treatment with thrombin will release the cloned protein from its GST moiety. The 
additional features of YEX makes it ~3,000 bp larger then pGEX.  This includes the copper 
(Cu2+)-inducible CUP1 promoter to increase and regulate expression of the fusion gene 




FIG 2.2: The bacterial and yeast expression vectors share many similarities. (A) pGEX 
and pYEX possess the same genetic elements. (B)The architecture of the MCS in both 










2.2.1 Preparation of pGEX plasmid for expression in E. coli 
DNA fragment coding for the mature sequences of Carcinoscorpius rotundicauda C-
reactive protein isoforms -1 and -2 (CrCRP-1 and -2) were separately amplified by PCR, 
using correctly-cloned pGEM-T-Easy plasmids as templates. Forward- and reverse-primers 
for CrCRP-1 contained BamHI and EcoRI restriction sites while those for CrCRP-2 contained 
EcoRI and XhoI restriction sites, respectively. Additionally, truncated forms of CrCRP-2 
were cloned. Primers used to PCR-amplify these contained EcoRI and XhoI restriction sites 
(TABLE 2.1; FIG 2.3 & FIG 2.4).  
Following digestion with the appropriate endonucleases, the inserts were ligated to 
linearised pGEX-4T-3 plasmids. T4 ligase (Roche) was used in the ligation mixtures.  
The ligation reactions were incubated overnight at 4˚C and the mixtures were 
employed in the transformation of E.coli Top 10 competent cells. These were prepared 
according to the rubidium chloride method described by Hanahan et al (1983). Frozen cell 
stocks were thawed from -80°C and inoculated in LB broth. These were incubated overnight 
at 37°C, with shaking at 230 rpm. 1 mL of the overnight culture was then transferred into 200 
mL of freshly-prepared LB and this was incubated at 37°C until OD600~0.7-0.8. The cells 
were pelleted by centrifugation at 6,000 x g for 10 min at 4°C. These were resuspended in 66 
mL of the activating solution (100 mM RbCl2, 50mM MnCl2, 30mM KAc, 10mM CaCl2, 
15% (v/v) glycerol) and chilled on ice for 2 h. Following this incubation, the cells were again 
spun at 6,000 x g for 10 min at 4°C. The cell pellet was resuspended in 16 mL of storage 
solution (75 mM CaCl2, 10 mM 3-[N-morpholino] propanesulfonic acid (MOPS), 10 mM 
RbCl2, 15 % (v/v) glycerol).  
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100 µL of competent E. coli cells were mixed with each ligation reaction and 
incubated on ice for 30min before heat-shock treatment at 37˚C for 5 min. The cells were then 
left on ice for at least two minutes. 800µL LB broth was added to the cells before they were 
left to grow at 37˚C for 1h. Transformed bacteria were then plated on LB agar and left to 
grow overnight, with ampicillin as a selecting agent.  
Resultant colonies were then isolated for liquid culture in LB broth. Isolated plasmids 
were mixed with fluorescent dideoxynucleotides (Big Dye ver 3.1, Applied Biosystems), 
subjected to PCR with specific primers. The end products were then screened on ABIprism 
377 (Applied Biosystems) (FIG 2.5). pGEX plasmids with CrCRP-1 and -2 sequences 
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TABLE 2.1: Forward (R) and Reverse (R) Primers used in the cloning of CrCRP-1 and 2. 













            CrCRP-1-FÆ 
1         AAGGTTAAATTTCCTCCGTCTAGTTCTCCGTCATTCCCACGACTAGTAATGGTAGGAACG 
1          K  V  K  F  P  P  S  S  S  P  S  F  P  R  L  V  M  V  G  T   
 
61        TTACCTGATCTGCAAGAAATTACCTTATGTTACTGGTTCAAGCTGCATCGCTTAAAGGGC 
21         L  P  D  L  Q  E  I  T  L  C  Y  W  F  K  L  H  R  L  K  G   
 
121       ACACCTCATATATTTTCTTACGCCAACTCTGAAACAGACAATGAGATTCTGACATCTCTG 
41         T  P  H  I  F  S  Y  A  N  S  E  T  D  N  E  I  L  T  S  L   
 
181       AATGAGCAAAATGATTTTCTCTTCAACATTCATGGGAAAACTCAGCTGAATGTACAGTGC 
61         N  E  Q  N  D  F  L  F  N  I  H  G  K  T  Q  L  N  V  Q  C   
 
241       AATAATAAAATACATGCTGGAAGGTGGCATCATGTATGTCACACGTGGTCATCATGGGAA 
81         N  N  K  I  H  A  G  R  W  H  H  V  C  H  T  W  S  S  W  E   
 
301       GGTGAGGCGACTACAGCCGTGGATGGTTTCCGTTGTAAAGGCAACGCAACTGGGAAAGCC 
101        G  E  A  T  T  A  V  D  G  F  R  C  K  G  N  A  T  G  K  A   
 
361       ATGGGAGTTACTTTTCGTCAAGGTGGCTTAGTCGTTCTTGGACAAGACCAGGATTCTGTC 
121        M  G  V  T  F  R  Q  G  G  L  V  V  L  G  Q  D  Q  D  S  V   
 
421       GGTGGTGGTTTTGATGCAAAACAAAGTTTGGTGGGAGAACTGAGCGAACTTAATCTTTGG 
141        G  G  G  F  D  A  K  Q  S  L  V  G  E  L  S  E  L  N  L  W   
 
481       GACATGGTTCTGAATCACGAGCAAATTAAACACTTGAGCGAGTGCGTGCATCCTTCGGAA 
161        D  M  V  L  N  H  E  Q  I  K  H  L  S  E  C  V  H  P  S  E   
 
541       AGACATATCTATGGAAACGTAATTCACTGGGATAAAACACAATTTCAGGCTTACGATGGA 
181        R  H  I  Y  G  N  V  I  H  W  D  K  T  Q  F  Q  A  Y  D  G   
 
                             ÅCrCRP-1-R 
601       GTTGCTCTTTCACCCAATGAAATCTGTGCTTAG 
















                                            CrCRP-2F-1Æ 
1         TCTAACTTCTGCTCTAGAGGAAGGTGAAATCAGCACAAAGGTTAAATTTCCTCCGTCTAG 
1           L  T  S  A  L  E  E  G  E  I  S  T  K  V  K  F  P  P  S  S  
 
61        TTCTCCGTCATTCCCGCGACTAGTAATGGTGGGAACGTTACCTGATCTGCAAGAAATTAC 
21          S  P  S  F  P  R  L  V  M  V  G  T  L  P  D  L  Q  E  I  T  
                                          CrCRP-2F-2Æ 
121       CTTATGTTACTGGTTCAAAATTCATCGCTTAAAGGCCTCACTTCATATGTTTTCGTACGC 
41          L  C  Y  W  F  K  I  H  R  L  K  A  S  L  H  M  F  S  Y  A  
 
181       TACCACTGGAAAAGACAATGAGATTCTGACATTTATAAACCAACAAGGTGATTTTCTTTT 
61          T  T  G  K  D  N  E  I  L  T  F  I  N  Q  Q  G  D  F  L  F  
 
241       CAACGTTCATGGGAGTCCCATGCTGAAAGTACAATGTCCAAATAAAATACACATTGGAAG 
81          N  V  H  G  S  P  M  L  K  V  Q  C  P  N  K  I  H  I  G  R  
             CrCRP-2F-3Æ 
301       GTGGCATCATGCATGTCACACGTGGTCATCATGGAAAGGTGAGGCGACTACAAACGTGGA 
101         W  H  H  A  C  H  T  W  S  S  W  K  G  E  A  T  T  N  V  D  
 
361       TGGTTTCCATTGTGTAGGTAACGCAACTGGAATCGCCACGGGAGCTACTCTTCGTCAAGG 
121         G  F  H  C  V  G  N  A  T  G  I  A  T  G  A  T  L  R  Q  G  
 
421       TGGCTTAGTTGTTCTTGGACAAGACCAGGATACTGTCGGTGGTGGGTTTGATGCAAATCA 
141         G  L  V  V  L  G  Q  D  Q  D  T  V  G  G  G  F  D  A  N  Q  
 
481       AAGTTTGGAAGGCGAACTGAGCGAACTTAATCTTTGGGACGCGGTTCTGAATCACGAACA 
161         S  L  E  G  E  L  S  E  L  N  L  W  D  A  V  L  N  H  E  Q  
                                    CrCRP-2F-4Æ 
541       AATTAAACACTTGAGTAAATGTGTGCATCATTCGGAACGACACATCTATGGAAACATAAT 
181         I  K  H  L  S  K  C  V  H  H  S  E  R  H  I  Y  G  N  I  I  
 
601       TCGCTGGGATAAAACACAATTTCGGGCTTACGATGGGGTTGTTCTTTCACCGAATGAAAT 
201         R  W  D  K  T  Q  F  R  A  Y  D  G  V  V  L  S  P  N  E  I  
 
661       CTGTGCTTAGATGACGTATTAGAAAGAAGAATTTGGAACCCGAGCACCGAAATGTAATTC 
221         C  A  *  ------------------------------------------------  
 
721       TGCTGTTTGTTGAACTNCTTNNTTATATANAANNGGTTATATATNATNCGCGGCTTTATA 
 
781       TCTATTAAAACTTCAAAGTATAATTTCNTGGATTTTTATGTAACATTCTGTGAACGTTCA 
 
841       TAATATGTTTTTGCTAGTTTAGAGATCATACGTCTACATTTTACTGTAAAAGGAGTGTTA 
                              ÅCrCRP-2R 
901       CTCTTTCCGCATATTATCTGGGTGTCTTTTTCCAATAAAGAATTTTTCCTGTTTTTAAAA 
 
961       GAAAAAAAAAAAAAAAA 
 
FIG 2.3: Cloning CrCRP-1 and -2.DNA (top line) and corresponding protein (bottom line) 
sequences of CrCRP-1(A) and -2 (B). Corresponding primer positions are indicated. 

















FIG 2.4: Schematic diagram of the cloning process. Red boxes of various lengths depict 









2.2.2 Preparation of pYEX plasmid for expression in yeast 
Following PCR with primers incorporating endonuclease restriction sites and 
digestion with the appropriate enzymes, CrCRP-2 was ligated into pYEX-4T-3 plasmids. As 
before, T4 ligase (Roche) was used in the reaction mixtures. The ligated mixture was used to 
transform E.coli Top 10 competent cells, using the same method as described above (2.2.1). 
Ampicilin was again incorporated into the LB agar as a selecting agent.  Resultant colonies 
were isolated and screened by DNA sequencing on ABIprisim 377 (Applied Biosystems) 
(FIG 2.5).  
pYEX plasmids with CrCRP -2 correctly incorporated were used to transform 
Saccharomyces cerevisaeAH109. This strain has the genotype MATa, ura3-52, his3-200, 
ade2-101, trp1-901, leu2-3, 112, gal4∆, met-, gal80∆, URA3: : GAL1UAS-GAL1TATA-lacZ. 
Selection of the pYEX plasmid in yeast is achieved by complementation of auxotrphic 
mutations. Specifically, the leucine  and uracil nutrient deficiencies of AH109 allows for the 
selection of transformed yeast because pYEX-4T-3 contains both Leu and Ura genes.  
Yeast competent cells were made according to the lithium acetate method first 
described by Ito et al (1983). Frozen yeast stocks were thawed and streaked on YPDA (20g/L 
Difco peptone, 10g/L yeast extract, 2% glucose, 0.003% adenine hemisulfate) agar and 
incubated at 30°C for 3-5 days. Four well-isolated single colonies with diameters ~2-3mm 
were then inoculated into 1mL YPDA in a 1.5mL microcentrifuge tube. The tube was then 
vortexed vigorously for 1min before its contents were transferred to 50mL of YPDA in a 
250mL culture flask. The liquid culture was incubated at 30°C with shaking at 260rpm for 16-
18h until OD600>2.0. 
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Thirty mL of the culture was transferred into 300mL of YPDA in a 2000mL culture 
flask to achieve OD600of ~0.2-0.3. The culture was incubated at 30°C for 3 h with shaking at 
260 rpm, to obtained culture of OD600~0.4-0.6. Yeast cells were harvested by centrifuging at 
1,000 x g for 5 min at 25°C. The cells were washed with 40mL TE (pH 7.5) and pelleted 
again by centrifugation under the same conditions. Finally, the competent yeast cells were 
resuspended in 1.5 mL LiAc/TE (0.1 M LiAc in TE). 
100 ng of each recombinant plasmid were mixed with 0.1 mg of herring testes carrier 
DNA (Clonetech). The mixture was added to 100 µL of competent yeast cells. 0.6mL of 
PEG/LiAc (40% polyethylene glycol (PEG), 0.1M LiAc in TE) was then added. These were 
mixed by vortexing at high speed for 10 s. Following incubation at 30°C for 30 min, 70 µL 
DMSO was added and mixed by gentle inversion. Samples were heat-shocked at 42°C for 15 
min and snap-cooled on ice for 2 min. Transformed cells were pelleted by centrifugation at 
14,000 x g for 10 s and resuspened in 500 µL of TE. 100 µL of each cell suspension was 
plated on SD minimal media agar (Clonetech), supplemented with –Leu-Ura DO amino acids 


















FIG 2.5: The principle of automated sequencing. At the end of a PCR reaction, all 
fragments terminate in a fluorescent-linked dideoxynucleotide. There are a total of 4 
fluorescent dideoxynucleotide species, corresponding to the four nucleotides that make up 
DNA. These DNA fragments are then separated on the basis of size as they move through an 
electrophoretic capillary. The fluorophore bound to each fragment is stimulated with a laser 
beam. The fluorescence is detected, and the information fed directly to a computer, which 











2.3 Expression and purification of recombinant CRPs 
 
In order to dissect the interactions of CRPs with proteins of the CFH, recombinant 
CRP-1 and -2 were produced as GST fusion proteins in both yeast and bacterial expression 
systems and used for GST pull-down analysis. The use of E. coli and S. cerevisae as 
expression hosts involves several advantages and drawbacks. 
E. coli is the leading host organism for the production of heterologous proteins from a 
wide range of source organisms (Weickert et al, 1996). Many of these systems have been 
translated into large-scale applications for commercial use. The reasons for this phenomenon 
are many and varied: E. coli is economical to culture, and the vast volume of literature 
amassed concerning it has made possible manipulations of its genome and physiology, so that 
up to 30% of its protein content can be composed of recombinant protein (Goeddel, 1990; 
Baneyx, 1999).  
Despite the prevalent use of E. coli for recombinant protein expression, there are 
several problems associated with its use. Firstly, each new gene transformed into E. coli 
presents its own unique expression problems (Hannig & Makrides, 1998). To date, no single 
method can yet be prescribed to ensure folding of every recombinant protein in native 
conformations, nor guarantee production of biologically function forms (Clark, 2001). Such 
lack of standardization has resulted in each and every recombinant protein being separately 
optimized for expression. Nevertheless, considerable effort has been directed at improving the 
performance and versatility of this workhorse microorganism and the results have highlighted 
general approaches that may be adopted to solve specific expression problems.  
Secondly, differences in codon usage between prokaryotes and eukaryotes can have a 
significant impact on recombinant protein production. For example, arginine codons AGA 
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and AGG, while common in Saccharomyces cerevisiae and eukaryotes, are rarely found in E. 
coli genes. The presence of such codons in cloned genes potentially affects mRNA and 
plasmid stability, as well as protein accumulation levels (Zahn, 1996). Such problems are 
usually addressed by site-directed mutagenesis replacement of rare codons with preferential 
codons of E. coli. Such problems are avoided are by using the pYEX vector for CRP 
expression in yeast, since the system already incorporates eukaryotic codon bias.  
High levels of expression—whether in yeast or bacteria host cells—often result in 
incorrectly-folded protein products that precipitate and present themselves as insoluble 
aggregates.  Protein in these “inclusion bodies” may be recovered by solubilization in 
denaturing agents, and its activity restored following a laborious process of renaturation 
(Mitraki &King, 1989). Like protocols involved in protein expression, recovery from 
inclusion bodies is a non-standardized process. The traditional approach to reducing protein 
aggregation is to lower culture temperatures. More recently, molecular chaperones that 
transiently interact with polypeptides to promote proper isomerization and cellular targeting 
have been used to reduce inclusion body formation (Thomas et al, 1997). Although fusion 
proteins were originally constructed to facilitate protein immobilization and purification, it 
became apparent that certain fusion partners significantly improved the solubility of their 
passenger proteins and thus prevent inclusion body formation within the cytoplasm (Baneyx, 
1999). Fusion expression systems include the glutathione S-transferase (GST) tag used in the 
experiments described here. It has been postulated that improved folding of passenger 
proteins results from the fusion partner reaching a native conformation very quickly after 
emergence from the ribosome. This, in turn, facilitates correct structural conformations in 
downstream units (Baneyx, 1999).   
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Because the proteins of interest in the present study interact with LPS, a PAMP 
located on the outer membrane of E. coli, there is the problem of host incompatibility. 
Bacteria expressing rCRPs exhibit inhibited growth and (in the case of CRP-1) cell death. 
This fact limited the intensity of IPTG induction—and thus recombinant protein yield—
possible for the bacterial expression system. The level of LPS present in purified recombinant 
CRPs was higher than that in the GST control. This is consistent with the fact that LPS 
present in the bacteria cell wall are solubilized during the cell lysis procedure. Petsch and 
Anspach (2000) have recently demonstrated that treatment of E. coli with a combination of 
Triton-X 114, EDTA and lysozme resulted in solubilization of all LPS from cell walls and 
subsequent removal of LPS from protein preparations. Hence, the strategy to overcome LPS 
contamination of recombinant CRPs is to target moderate yields from E. coli expression and 
to remove LPS efficiently following cell lysis when proteins are in the soluble cytoplasmic 
fraction. 
The harsh conditions necessary to lyse cells creates similar problems of low yield from 
yeast. In this study, glass beads (0.45 mm; Sigma) were used to break cells mechanically. This 
procedure is flexible and can be carried out on cultures of any size and is particularly useful 
when assaying multiple small cultures. However, the extent of cell lysis varies across samples 
and proteolysis of target proteins result from excessive heat generated during the procedure.   






2.3.1  Large-scale expression of GST-CRPs in bacterial culture 
Correctly cloned recombinant plasmids were transformed into E. coli strain BL21 DE3. 
This was a suitable expression as it was protease-deficient, so preserving the integrity of the 
recombinant protein produced. As a control, pGEX-4T-3 plasmids were separately 
transformed into BL21.   
To obtain GST-tagged recombinant CRP-2 protein, a single colony of E. coli BL21 
transformant was inoculated into 5mL of 2x YTA media containing 100µg/ mL of ampicilin 
and cultured overnight at 37°C with shaking at 230 rpm. 100µL of the overnight culture was 
then added to 1L of 2x YTA media.  Bacterial culture was grown at 25 °C, with shaking at 
230 rpm, until OD600nm ~ 0.6-0.8. To induce recombinant protein expression, isopropyl-1-
thio-β-D-galactopyranoside (IPTG) was added to a final concentration of 0.1 mM when the 
culture attained an OD600 of 0.6. 3 h post-induction, the cells were harvested by centrifugation 
at 5,000 x g for 5 min at 4°C. The medium was removed and the bacterial pellet was washed 
with 10 mL ice-cold Tris-buffered saline, pH7.4 (TBS). The cells were re-suspended in 50 mL 
ice-cold TBS and French Pressed at 15 kPa. Cell debris was removed by centrifuging the 
lysate at 9,000 x g for 1hr at 4°C.  
 In contrast to CrCRP-2, GST-CRP-1 exhibited significant toxicity as an intracellular 
fusion protein. Excessive IPTG induction, or prolonged culture times resulted in bacterial host 
cell death. In order to induce CrCRP-1 expression, 2% glucose was added to the growth 
medium to decrease basal expression associated with the lac promoter, located between the 
laqIq repressor and the tac promoter in pGEX. IPTG was added to a final concentration of 
0.01 mM and the culture was induced for only 1 hour. The cells were then harvested as 
described above. E coli cell lysate containing the GST protein was similarly prepared. This 
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was obtained by IPTG induction of bacterial cultures transformed with pGEX-4T-3 plasmids 
as a negative control. 
2.3.2 Expression of GST-CRP-2 in yeast culture 
Like the bacteria colonies, yeast transformants were initially grown without the stress 
of producing foreign proteins. Single colonies of transformed yeast were inoculated into YPD 
liquid media (1% yeast extract, 2% peptone, 2% dextrose) grown overnight at RT. Five mL of 
this starter culture was then inoculated into 1 L of fresh medium contained in shaker flasks, 
for incubation at RT, with continuous shaking at 260rpm.  0.1mM CuSO4 was added when 
OD600~0.7 of the culture to induce expression of recombinant fusion protein. Cells were 
harvested 3 h post-induction by centrifuging the culture at 7,000 x g for 5 min. The cell pellet 
was washed with breaking buffer (1 mM PMSF, 1 mM EDTA, 5% (v/v) glycerol dissolved in 
TBS, pH 7.4) and resuspended in 40 mL of breaking buffer. Cells were lysed by glass beads 












2.3.3 Capturing fusion proteins by affinity column chromatography  
Glutathione Sepharose 4B (Amersham Biosciences) was supplied as a 75% slurry. The 
beads were sedimented by centrifugation at 10, 000 x g for 5 min at 4°C. The supernatant, 
containing 20% ethanol as a preservative, was removed. The beads were washed by vortexing 
with 10 x slurry volume ice-cold TBS and re-sedimented under the same conditions as above. 
The beads were finally resuspended in 0.75 x slurry volume TBS to yield a 50% working 
slurry. This was packed into 1 mL plastic disposable columns. Before use, these columns 
were equilibrated with 10mL ice cold TBS.  Using a peristaltic pump, bacterial supernatant(s) 
containing GST-CRP were repeatedly cycled through the 50% slurry columns at 4°C 
overnight. Supernatant containing GST was similarly incubated as a control. Following 
washing with TBS, Elution Buffer A (50mM Tris-Cl, 20mM reduced glutathione, pH 8.0) 
was incubated with the protein-bound matrix at RT for 30min before the target protein was 
removed from the column. The kinetics of non-specific protein removal and subsequent target 
protein elution was monitored by passing all flow-through from the column across a 280nm 
UV detector (Amersham). The isolated proteins were dialysed against TBS, 10mM EDTA at 
4°C overnight, with three changes of buffer. The resultant dialyzed protein solutions 
contained GST-tagged CrCRP-1 or -2. 
2.3.4 GST tag removal by thrombin digestion 
To obtain CrCRP-2 without the GST motif, 2 units of thrombin (Amersham) were 
added to matrix-bound fusion proteins following washing with TBS. The mixture was 
incubated for 24 h at 4°C and the enzymatically-cut proteins were removed from the matrix 
by eluting with TBS. The eluant was then incubated with benzamidine sepharose (Amersham) 
for 1 h at 4°C to remove excess enzyme.  
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2.3.5 LPS removal by Triton X-114 treatment  
Protein solutions containing either GST-CrCRP-2 or untagged CrCRP-2 were 
subjected to LPS removal using Triton X-114,according to the method developed by Petsch 
and Anspech (2000). Triton X-114 was added to the protein preparation to a final 
concentration of 1%. The mixture was incubated at 4°C for 30 min with constant stirring to 
ensure a homogenous solution. The sample was then transferred to 37°C for 10 min and 
centrifuged at 20,000 x g for 10 min at RT. The resultant aqueous phase containing the 
protein was removed and subjected to Triton X-114 phase separation for another 2 cycles. The 
anti-microbial functions of the resultant, purified proteins were assessed by recombinant 
Factor C (rFC) assay. 
 
FIG 2.6: Removal of endotoxin by two-phase extraction with Triton X-114. Below 20°C, 
Triton X-114 allows dissociation of endotoxin from the protein in a homogenous solution. At 
higher temperatures, Triton X-114 readily associates with the endotoxin, in a non-polar phase. 
The aqueous phase (containing protein) is then cycled through fresh Triton X-114 until 






2.3.6 Recombinant Factor C (rFC) assay to monitor LPS removal 
Analysis of LPS contamination of rCrCRP-2 was achieved using Pyrogene, a 
recombinant Factor C (rFC)-based endotoxin detection kit (Cambrex Inc). The rFC is 
activated in the presence of LPS to catalyze hydrolysis of a synthetic substrate. This reaction, 
in turn, releases a fluorescent product which is quantifiable at excitation and emission 
wavelengths of 380 nm and 440 nm, respectively. Fifty microlitres of protein solution 
containing various amounts of CrCRP-2 was dispensed into the wells of a sterile microtitre 
plate (Nunclon™; Nunc), followed by 50 µL of freshly-reconstituted rFC reagent. 
Fluorescence at 440 nm of each well was monitored after 30 min incubation at 37˚C. CrCRP-
2 which had not been subjected to Triton-X 114 LPS removal and GST were included as 
positive and negative controls, respectively. Only proteins samples with LPS levels 
comparable to the buffer background were used for downstream protein characterizations.  
2.3.7 Protein quantification and determination of protein expression levels 
 
Total protein in the lysates and extracts obtained from various purification steps were 
quantified using the Bradford assay (1976). To determine the expression level of recombinant 
CRPs, different fractions were electrophoresed using SDS-PAGE. Proteins were verifed by 
Western blotting and the relative amounts were quantified densitometrically using Quantity 
One software (Biorad). In each case, the protein band(s) of interest were quantified against the 






2.4 Checking the interactions of CrCRPs by GST pull-down assays 
In order to dissect the interactions of CRPs with other proteins of the cell-free 
hemolymph, recombinant CRP-1 and -2 were produced as GST fusion proteins and used for 
GST pull-down analysis. GST pull-down is a coprecipitation method, whereby the GST 
moiety of the fusion protein binds glutathione linked to sepharose beads. Addition of cell-free 
hemolymph to the affinity matrix then allows the isolation of CRP interacting partners. 
Washing of the affinity matrix removes unbound and/ or non-specifically bound proteins. The 
GST-tagged “bait”, together with its interacting partners, remains tethered to matrix and are 
subsequently eluted. Bound protein complexes were analyzed by SDS-PAGE and mass 
spectrometry (MS). The mechanism of GST pull down is illustrated in FIG 2.7.   
Purified GST and GST fusion proteins were separately spiked with freshly-prepared 
CaCl2, MgCl2 and FeCl2 solutions, to a final concentration of 10 mM. These were incubated 
overnight with freshly-prepared glutathione sepharose 4B slurry.  Beads containing bound 
proteins were sedimented at 5, 000 x g for 5 min at 4°C and the supernatant removed. 
Hemolymph samples were introduced to aliquots of the bound slurry. The mixture was again 
incubated overnight at 4°C. The beads and its associated proteins were washed three times 
with TBS, 0.35% Tween-20. Elution Buffer B (50mM Tris-Cl, 10mM reduced glutathione, 
pH 8.0) was then added and the mixture incubated at RT for 20min, with constant mild 
agitation. The suspension was centrifuged at 1, 000 x g for 5 min at 4°C and the buffer 
removed. This elution was repeated twice with fresh buffer and the two fractions were 
combined. Divalent ions (Ca2+, Mg2+ and Fe2+) to determine whether their presence affected 
the interactions of CRP-2, since hCRP is known to harbour a calcium-binding pocket. 
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Infected hemolymph was tested alongside naïve samples to determine if infection alters the 
interactions of CRP-2. GST was included as a negative control.  
Eluant were analysed on 12 % SDS-PAGE gels and stained with Coomassie Blue. 
Interactions were partially confirmed by western blotting with CRP antiserum and GST 
antibodies. Protein bands of interest were excised for identification by mass spectrometry, as 













FIG 2.7: Overview of the mechanism of GST pulldown. CRP-2 is expressed as a 
recombinant GST-fusion protein and (1) is immobilized on glutathione beads by binding 
between glutathione and GST. (2) Cell-free hemolymph (CFH) was then incubated with the 
beads. Some proteins present in the CFH would bind to CRP-2. (3)These were eluted and 
analyzed by SDS PAGE. Because GST-CRP-2 is expressed as a single contiguous gene 
construct, the two are not separated in a denaturing gel. Protein bands in the one dimension 
(1D) gel may contain mixtures of proteins. The bands may then be excised and the proteins 










2.5 Antiserum production and immunoblotting of proteins 
CRP antiserum was raised in rabbits. CRP, purified from the plasma of Limulus 
polyphemus on the basis of affinity for PC, was purchased from Sigma. This mixture contains 
both CRP-1 and -2, since both isotypes demonstrate binding to PC (Iwaki et al, 1999). The 
resultant serum would thus react against both CRP-1 and -2.  
100µg of protein was emulsified in complete Freund’s adjuvant (Sigma) and 
administered intramuscularly. After two weeks, the rabbits were given 100µg of the antigen 
dissolved in incomplete Freund’s adjuvant (Sigma). Thereafter, the rabbits were injected with 
100µg CRP dissolved in sterile water every two weeks as a booster, for 6 weeks. Blood was 
drawn before antigen stimulation and, thereafter, once every fortnight. Antibody titer was 
monitored periodically by ELISA assays. The blood was centrifuged at 1,500 x g for 10 
minutes at 4°C to remove hemocytes and the serum was stored at -30°C.  
For immunoblotting, gels of SDS-PAGE were transferred to PVDF membranes (Bio-
rad), using an electroblot apparatus (Bio-Rad) at 60 V for 1h. The membranes were blocked 
with skim milk (Difco) and treated with the rabbit antiserum. Horseradish peroxidase-
conjugated goat anti-rabbit IgGs were then added. Immunoreactive proteins attached to 
membranes were visualized after horseradish peroxidase reduction of chemiluminescent 
substrates (West Pico). Some membranes were then stripped of primary and secondary 
antibodies using a buffer containing detergents and reducing agents (2% SDS; 100mM β-





2.6 In-gel digestion and protein identification by mass spectrometry 
Protein bands of interest were excised from SDS-polyacrylamide gels.  The gel pieces 
were washed with 50 mM NH4HCO3:/ 50% (v/v) acetonitrile and dehydrated with acetonitrile.  
Proteins were then reduced with 10 mM DTT in 100 mM NH4HCO3 at 57°C for 1 h, and 
alkylated by 55 mM iodoacetamide in 100 mM NH4HCO3 at room temperature for 1 h.   
In-gel digestion was carried out with 12.5 ng/µL trypsin at 37°C for 15 h.  The 
resultant peptide fragments were extracted from the gel with 20 mM NH4HCO3. This was 
followed by extraction with 5 % formic acid in 50 % aqueous acetonitrile and, finally, with 
100 % acetonitrile. The combined protein mixture was dried in a speed-vac and identified by 
MALDI-TOF (Voyager-DE™ STR Biospectrometry™ Workstation, PerSeptive Biosystems) 
and by MALDI-TOF MS/ MS analysis (4700 Proteomics Analysis, ABI) at the Protein and 
Proteomics Centre, NUS.   
MALDI is a high energy process that, under certain conditions, leads to observable 
fragmentation of the analytes (in this case, proteins). The protein solution is co-precipitated 
with an ultraviolet (UV) light-absorbing matrix on a metal probe tip. Irradiation and a short 
UV laser pulse sublimates the matrix, protonates peptide fragments and allows ionized 
peptides to be ejected into a vaccum. These ionized peptides are accelerated through a strong 
electric field in the spectrometer and recorded as they pass detection plate(s) (Vorm et al, 
1994).   
In this case, laser intensity was 4,900 and the range of mass capture was set between 
800 to 3500 m/z at the detection plate(s). Mass spectra were obtained by averaging 2500- 
3000 individual laser shots. To provide reference points for interpreting experimental data, 
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peptides of known mass are measured first and subsequent data calibrated against these 
parameters. Calibration of spectra was performed with the following proteins: 
 
Protein Mass 
Angoistensin I 1296.685 
des-Argl-Bradykinin 904.468 




ACTH (18-39) 2465.199 
ACTH (7-38) 3657.929 
 
Table 2.2: Proteins used for calibration of MALDI TOF MS/MS 
  The peptide mass fingerprint (pmf) of the digested proteins were analysed by Mascot 
(http://www.matrixscience.com) against the Mass Spectrometry protein sequence Data Base 
(MSDB).  Peaks of pmfs were also matched to known proteins following in-silico digestion 








2.7 Antimicrobial assays 
The following bacteria strains were used for determination of antimicrobial activity: 
Escherichia coli ATCC25922, Pseudomonas aeruginosa ATCC27853 and Staphylococcus 
aureus ATCC25923. E. coli and S. aureus were choosen to represent Gram-negative and –
positive bacterial species respectively. The two major groups of bacteria are known to vary in 
the architecture of their cell walls and the major PAMPs presented on them. CrCRP-2 was 
isolated from an LPS-conjugated column (Ng et al, 2004), and it was postulated that CrCRP-2 
would exhibit activity against E. coli and P. aeruginosa due to the presence of LPS on their 
cell walls. It would, however, be interesting to see if CrCRP-2 might bind PAMPs associated 
with Gram-positive bacteria as well.  
Pseudomonas aeruginosa ATCC27853 has been adopted as a control strain for 
susceptibility testing by CDC. It was included in the present study as this bacterial species is a 
leading cause of nocosomial infections, as discussed above (Clarke, 1990). Demonstration of 
the antimicrobial activity of CrCRP-2 against a clinically important pathogen is the first step 
towards the development an antimicrobial agent.  
2.7.1 Bacteria growth inhibition/ bactericidal assays 
The antimicrobial effects of rCRP-2 were determined by analysis of its minimum 
inhibitory concentration (MIC) and its minimum bactericidal concentration (MBC) against E. 
coli, P. aeruginosa and S. aureus. The MIC and MBC determination methods are based on 
those used by the Hancock laboratory (Amsterdam, 1996). 
All bacteria were grown in tryptosoy broth (TSB; Oxoid) at 37°C overnight, with 
shaking at 180 rpm. Bacteria culture was collected and washed twice with Tris-buffered saline, 
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pH 7.4 (TBS) and adjusted to final concentrations of 1X 105 to 1 X 109 cells per mL with half-
strength Muller-Hinton broth (MHB; Becton Dickinson).  
Recombinant CRP-2 (rCRP-2) was solubilised in TBS to obtain 10 times the maximal 
concentration tested.  Serial dilutions of the protein solution were done to obtain test solutions 
at 10 times the required test concentrations. 
11µL of each 10x test solution was then added to 100µL of bacterial suspension. The 
mixtures were incubated in ELISA plate wells at 37°C, with shaking at180 rpm. Various 
OD600 readings were taken at 0 h, 2h, 3h, 6h, 12h and 24h to monitor bacterial growth. The 
density of the bacteria following incubation with rCRP-2 was determined by the Miles and 
Misra method (1938). At various time points, part of each reaction mixture was serially 
diluted 10-fold and 20µL of each dilution was dropped onto tryptosoy agar (TSA; Oxoid). 
These were incubated at 37°C to monitor and visualize bacterial growth. As a control, TBS 
was added to the bacterial suspensions and the mixture was similarly incubated before its 
OD600 was read and the mixture was plated. The MIC was taken to be the lowest 
concentration of rCRP-2 that reduces growth by 50% or more, relative to the control.  
In addition, the number of colony-forming units (CFU) was determined. 10µL of 
serially diluted cultures were plated on Muller Hinton agar (MHA; Becton Dickinson) and 
incubated at 37°C for 18h. TBS was similarly used as a control. Cultures that exhibited 
contamination were discarded and their corresponding data excluded from analysis. The MBC 
was taken to be the lowest concentration of rCRP-2 that prevents residual bacteria colony 




2.7.2    Bacterial agglutination assay 
Bacterial agglutination was performed using live P. aeruginosa ATCC27853 cells, 
according to the method of Lanyi and Bergan (1978). The culture was grown to mid log phase 
and centrifuged. The bacteria pellet was resuspended in saline so the concentration was ~5 X 
108 bacteria/ mL. The cell preparation was then incubated with varying concentrations of 
rCRP-2 at 37°C.  
The agglutination assay was performed on glass slides and the results observed after 3 
to 5 minutes. The agglutination of live cells is characterized by a coarse granular bacterial 
clumping. 
2.7.3 Neutralization of CrCRP-2 activity by LPS and its substructures 
 Because CrCRP-2 was first isolated a LPS-binding protein in the cell-free hemolymph 
of the horseshoe crab (Ng et al, 2004), it was postulated that the antimicrobial activity the 
protein exhibited was due to its ability to recognize and bind this PAMP that is present on the 
surface of Gram-negative bacteria. In order to test this hypothesis, 2.5 µM of recombinant 
CRP-2 was incubated with of Salmonella minnesota rough mutant (Re 595) LPS (Sigma) at 
ratios of 1:1, 1:2 and 1:5 for up to 3 h at RT. This strain of S. minnesota LPS consists of lipid 
A and 2-keto-3-deoxyoctonate (KDO) and represents the conserved, minimum structure of 
LPS (Raetz C R H, 1990). In addition, CrCRP-2 was also separately incubated with 
phosphorylcholine (PC; Sigma), KDO (Sigma) and lipid A. These are integral constituents of 
LPS and the experiments aimed to confirm the substructure(s) of LPS to which rCRP-2 bound 
to exert its antimicrobial effect.   
 The incubated protein solutions containing rCRP-2 were then taken for growth 
inhibition and bactericidal assays, as described above, of Pseudomonas aeruginosa 
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ATCC27853 that had been resuspended in saline so its concentration was ~1 X 105 bacteria/ 
mL. 
2.8 In silico analysis of DNA and protein sequences 
 
Alignment of DNA and protein sequences to homologous sequences was generated by 
DNAman Version 4.15 (Lynnon Biosoft). 
 Secondary structural predictions of protein sequences were analyzed using PSIPRED 
version 2.4 (McGuffin et al, 2000). Tertiary structural predictions were generated by 
comparative protein modeling using the first approach in SWISSMODEL (Guex & Peitsch, 
1997). Potential glycosylation sites in proteins were scanned by the YinOYang1.2 prediction 
server (Gupta et al, manuscript in preparation). These programs were assessed as “freeware” 




3.1 Interactions of recombinant CRP-1 and -2  
 
CRP-1 and -2 are the major extracellular lectins that bind LPS (Ng et al, 2004). 
In contrast to a single CRP gene in humans, horseshoe crabs possess numerous CRP 
genes. These may be grouped into three isotypes, based on sequence homology and 
biochemical characterizations. The nature of CRP heterogeneity and the roles of 
different isoforms remain unclear. Additionally, the LPS-binding complex consists of 
other plasma proteins (Ng et al, 2004) and the exact protein-protein interactions within 
this complex are unclear.  
In order to elucidate the roles of CRP-1 and -2 during GNB infection and 
recognition, and to verify differences in their interaction, isolated CRP-1 and -2 genes 
were cloned into bacteria and yeast expression vectors. The resultant recombinant 
proteins were used for GST-pull down experiments. 
3.1.1 Comparison of expression and purification efficiencies of recombinant 
CRP-1 and -2 
To determine expression and purification levels of recombinant proteins from E. 
coli and S. cerevisae, samples from the different purification steps were quantified by 
Bradford assay before separation by SDS-PAGE. Recombinant CRP-1 and -2 were 
verifed by Western blotting with GST antibodies and CRP antiserum. The relative 
amounts of protein were then quantified densitometrically. Combining the 
densitometric analysis results with quantitative and qualitative information, it was 
possible to compare the efficiency of expression and purification from different hosts 
systems. The results are shown in TABLE 3.1. 
The level of expression of rGST-CRP-2 in bacterial host cells was slightly 
higher than that of rGST-CRP-1, although both proteins exhibited similar purification 
and recovery efficiencies. The lower absolute recovery of the rGST-CRP-1 may be 
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attributable to the pronounced toxicity effects of the fusion protein. This was observed 
as (1) reduced cell pellet size following harvesting, (2) changes in the colour and lack 
of consistency of the pellet obtained, and (3) little or no soluble fusion protein product 
in the cell lysate following excessive IPTG induction or prolonged culture times.  
In contrast, the yield of rGST-CRP-2 and untagged CRP-2 from yeast was 
markedly less than those from E. coli. Examination of TABLE 3.1 shows that the 
recovery of proteins from each purification step is actually higher in proteins derived 
from yeast. The low yield of rCRP-2 expressed in yeast can be traced to the small 
amount of recombinant protein obtained in supernatant following cell lysis. As 
discussed above, mechanical breakage of yeast cells with glass beads is non-uniformly 
efficient and may cause heat-induced degradation of target proteins. Both factors would 
contribute towards the low recovery of recombinant proteins following cell lysis.  
3.1.2 Interactions of CRPs are enhanced in the presence of calcium, as well as 
during infection  
CRP-1 and -2 were the predominant lectins previously isolated via LPS affinity 
chromatography (Ng et al, 2004). In addition, several other proteins bands were also 
co-eluted with CRPs. To better understand the interactions of these isoforms with 
hemolymph proteins, recombinant CRP-1 and -2 were separately fused to GST for pull 
down experiments. The fusion proteins were immobilized onto glutathione sepharose 
4B beads, an arrangement that mimics the clustering of active, pathogen-bound CRP. 
Other reports have shown that human CRP, when bound to a multivalent ligand, is 
recognized by C1q and can efficiently initiate the formation of C3 convertase through 
the classical pathway (Kaplan & Volanakis, 1974). In addition, soluble fibronectin and 
fibrinogen binds only to substratum-attached human CRP; no interaction was observed 
when both proteins are in the soluble phase (Salonen et al, 1984). Thus, the utilization 
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of a fusion protein-affinity matrix system is necessary for elucidating CRP interaction 
partners in vitro. 
 The immobilized proteins were incubated overnight with cell-free hemolymph 
(CFH) and eluted fractions were visualized on SDS-PAGE. Both rGST-CRP-1 and -2 
pull down a repertoire of CFH proteins. The interactions were specific to CRPs, since 
affinity matrix alone and GST-bound matrices failed to pulldown CFH protein (FIG 
3.1). Both CRP-1 and -2 interact with proteins of naïve CFH. These represent the pre-
existing pool of CRP-interacting partners, and suggest that a “pathogen-recognition 
complex”, with CRP as a core component is able to assemble rapidly and efficient 
immediately following GNB invasion. The interactions were facilitated in the presence 
of calcium, as evidenced by an increase in intensity of interacting proteins seen in 
PAGE. This effect was specific, since addition of divalent magnesium ions did not 
produce a similar effect.  
To investigate the involvement of acute-phase proteins induced by GNB 
infection, horseshoe crabs were infected with a sublethal dose of Pseudomonas 
aeruginosa (Ng et al, 2004).  CRP-binding proteins were then isolated 1 hour post 
infection (hpi).  The amount of interacting proteins increased, relative to the complex 
isolated from uninfected CFH. This suggests infection caused an upsurge of immune-
related proteins to be released into the CFH. Some of these are constitutively 
expressed—albeit at a higher lever—while others are possibly induced during infection. 
Calcium ions also had an enhancing effect on the infected complex. (FIG 3.1& 3.2).  
These results were confirmed by densitometric analysis of the individual PAGE gel 
lanes (FIG 3.3).    
Human CRP (hCRP) is known to exhibit calcium-dependent interactions. In 
particular, the calcium-dependent interaction of CRP with the phosphorylcholine (PC) 
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moiety (present in C-polysaccharide, where it first isolated) has been the main 
paradigm for CRP characterization (Kaplan et al, 1977). It is perhaps not surprising that 
one or several isoforms in the horseshoe crab CRP repertoire should mimic this 
calcium-dependency. Interestingly, horseshoe crab CRP-1 and -2 does not exhibit this 
behaviour towards PAMPs such as LPS (Ng et al, 2004), but towards its downstream 
interactions partners. 
While hCRP is known to be an important mediator of immune responses 
(Gewurz et al, 1982; Gewurz et al, 1995 and Volanakis, 1982), infection-induced 
enhancement of CRP interactions has never been reported. This increase may be 
mediated by changes in both the intensity of interactions, as well as the composition of 
the complex. More pertinently, an increase in CRP-interacting partners following 
infection strongly suggests that CRP, as a pivotal innate immune defense molecule, 
does not function in isolation, but requires CFH protein partners to support their 


























(mL) Protein   rGST-CRP-2       
    
mg/ 
mL Total (mg) 
mg/ 






Lysate 60 1.54 92.4  0.077 4.8 100% 0.052 1
Bacterial 
Supernatant  50 1.24 62  0.066 3.303 68.80% 0.053 1.02
(soluble proteins)          
Glutathione 
Sepharose 4B 15 0.148 2.23  0.124 1.855 38.70% 0.832 16
Dialysis 15 0.121 1.82  0.103 1.545 32.23% 0.849 16.33
Thrombin/ 
Benzamidine 15 0.128 1.92       
LPS removal 14.7 1.036 1.52  0.089 1.301 27.10% 0.856 16.46




(mL) Protein   rGST-CRP-1       
    
mg/ 
mL Total (mg) 
mg/ 






Lysate 60 1.36 81.6  0.064 3.84 100% 0.047 1
Bacterial 
Supernatant  50 1.19 59.5  0.058 2.9 75.50% 0.049 1.04
(soluble proteins)          
Glutathione 
Sepharose 4B 15 0.123 1.9  0.104 1.6 41.67% 0.842 17.91
Dialysis 15 0.119 1.8  0.101 1.515 39.45% 0.842 17.91
Thrombin/ 
Benzamidine            
LPS removal 14.5 0.098 1.4  0.079 1.145 29.81% 0.818 17.4




(mL) Protein   rGST-CRP-2        
    
mg/ 
mL Total (mg) 
mg/ 






Lysate 60 2.13 127.8  0.023 1.4 100% 0.011 1
Bacterial 
Supernatant  50 2.07 103.4  0.024 1.21 86.43% 0.012 1.09
(soluble proteins)          
Glutathione 
Sepharose 4B 15 0.071 1.06  0.066 0.988 70.57% 0.932 84.72
Dialysis 15 0.069 1.03  0.0648 0.972 69.42% 0.947 86.1
Thrombin/ 
Benzamidine  15 0.067 1.008       








     
rCRP-2         
mg/ mL Units' (mg) Recovery Units'/ Total Purification (-fold) 
0.077 4.8 100% 0.052 1
0.066 3.303 68.80% 0.053 1.02
    
0.124 1.855 38.70% 0.832 16
0.103 1.545 32.23% 0.849 16.33
0.096 1.44 30.00% 0.75 14.42
0.086 1.26 26.25% 0.82 15.7
     
          
          
     
     
     
     
     
     
     
     
rCRP-2          
mg/ mL Units (mg) Recovery Units/ Total Purification (-fold) 
0.023 1.40 100% 0.011 1
0.024 1.21 86.43% 0.012 1.09
    
0.066 0.988 70.57% 0.932 84.72
0.065 0.972 69.42% 0.947 86.1
0.055 0.825 58.92% 0.818 74.36
0.048 0.706 50.43% 0.766 69.36
 
TABLE 3.1 (this & previous page): Assessing the expression and purification 




M: protein molecular weight marker
1: matrix + naïve CFH
2: matrix + infected CFH
3: matrix + GST + naïve CFH
4: matrix + GST + infected CFH
5: matrix + GST-CRP-2 + naïve CFH
6: matrix + GST-CRP-2 + infected CFH
7: matrix + GST-CRP-2 + Ca2+ + naïve CFH
8: matrix + GST-CRP-2 + Ca2+ + infected CFH
9: matrix + GST-CRP-2 + Mg2+ + naïve CFH
10:matrix+ GST-CRP-2 + Mg2+ + infected CFH
FIG 3.1: Interactions profiles of GST-CRP-2 with proteins of naïve and infected CFH. 
The effects of divalent calcium and magnesium ions were examined as well. 70kDa, 
40kDa, 35kDa & 25kDa protein bands (arrowed in red, blue, green and yellow, 
respectively) from individual lanes were excised and analyzed by in MALDI MS/ MS to 
determine the identity of CRP-2 interacting partners.
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1: matrix + GST-CRP-1 + naïve CFH
2: matrix + GST-CRP-1 + infected CFH
3: matrix + GST-CRP-1 + Ca2+ + naïve CFH
4: matrix + GST-CRP-1 + Ca2+ + infected CFH
5: matrix + GST-CRP-1 + Mg2+ +naïve CFH
6:matrix+ GST-CRP-1 + Mg2+ +infected CFH
M: protein molecular weight marker
FIG 3.2: Interactions profiles of GST-CRP-1 with proteins of naïve and infected 
CFH. In addition to the identification of p28, p35, p40 and p70 (arrowed in red, blue, 
green and yellow, respectively) by MALDI MS/MS, a novel protein interacting 







FIG 3.4: pmf profiles of CRP-2 interacting proteins from naïve (N) and infected (I) CFH. 
P70 matched to hemocyanin (peaks annotated in black), p40 and p35 to CL-5A and B (red and 
blue, respectively) and p28to CRPs (yellow). Peptide fragments whose mass match the m/z peak 






FIG 3.5: CRP-1 interacts preferentially with GBP.(A) pmf profiles of GST-CRP-1 
interacting proteins. Both p28 and p50 matched to GBP (peaks annotated in green). 
(B) GBP protein isolated from Carsinoscorpius. Sequences masses that match to the 
m/z peak values are indicated in green. 
MKNIMYFSLV MLLLTFLVVS PTLAEWTHIN GKLSHLTVTP RFVWGVNNVH
DIFRCTRPCTGSNWIKVEGS LKQIDADDHE VWGVNSNDNI YKRPVDGTGS 
WTQIKGGLKHVSASGYGYIWGVSSKDQIFKCPKPCNGEWELVDGSLKQVD 
GGRDLVYGVN QNDEIYRRPV DGSGVWENIPGKLKHISGSG SWEVFGVNC

















M: protein molecular weight marker
1: matrix + gly-CRP-2
2: matrix + gly-CRP-2 + naive CFH
3: matrix + gly-CRP-2 + Ca2+ + naïve CFH
4: matrix + gly-CRP-2 + infected CFH
5: matrix + gly-CRP-2 + Ca2++ infected CFH
a: as determined by densitometric analysis of Fig 3.6A Lane 5.
b: as determined by densitometric analysis of Fig 3.6A Lane 4.
c: as determined by densitometric analysis of Fig 3.1 Lane 8.
d: as determined by densitometric analysis of Fig 3.1 Lane 6.
e: as determined by densitometric analysis if Fig 3.1 Lane 4.
FIG 3.6: Glycosylation enhances CRP-2 interactions and recruits a fragment of hemocyanin
to the “pathogen-recognition complex”. Inspection of the (A) Pull down profiles of GST-gly-
CRP-2 suggest that the interactions are not Ca2+ -dependent. This was confirmed by (B) 
densitometric analysis of the SDS_PAGE profiles. (C) In comparison with the MALDI pmfs of 
proteins pulled down by non-glycosylated (gly) CRP-2 (Fig 3.4), the MALDI pmfs of proteins 
pulled down by gly-CRP2 show both p40 and p70 to be hemocyanin, suggesting that 








FIG 3.3: Densitometric analysis of CRP-1 and-2 interactions with CFH proteins. 
The results indicate that interactions of both proteins increase in the presence of calcium 
and following infection.   
 
3.1.3 CRP-1 and -2 interact preferentially with GBP and CRPs respectively 
 
 In order to identify CRP-interacting partners, protein bands of interest were 
excised and analyzed by mass spectrometry (MALDI MS/MS).  Resultant peptide mass 
fingerprints (pmfs) were matched to known proteins by Mascot search. In addition, 
RACE fragments of homologous proteins were subjected to in silico digestion and the 
peptide masses matched to the m/z values in individual pmfs. 
 MALDI-derived pmfs of the 70 kDa, 40kDa, 35kDa and 28kDa proteins bands 
(p70, p40, p35 and p28, respectively) in the CRP-2 interacting profiles were matched by 
Mascot search to protein in the mass spectrometry database (MSDB). In particular, p70 
matched to hemocyanin HR6 subunit (NCBI ascension number: AAB36150), p40 and 
p35 matched TL-5 (1JC9A & BAA84189) from the Japanese horseshoe crab, Tachypleus 
tridentatus, while p28 matched CRPs (AY647269-77).  Because other members of the lab 
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have previously isolated RACE fragments of TL-5 homologues (unpublished data) and 
hemocyanin (Jiang et al, manuscript in preparation) from Carcinoscorpius rotundicauda, 
we subjected these gene products to in silico trypsin digestion analysis. As a result, the 
m/z peak values in all pmfs were matched to putative peptide fragments of 
Carcinoscorpius-derived proteins (FIG 3.4). Henceforth, p35 and p40 are referred to as 
Carcinolectins-35 and –40 (CL-35 and CL-40). Interestingly, not all peaks in the p35- 
and p40-derived pmfs could be matched to CL RACE fragments. This suggested the 
existence of some CL isoforms that have not been isolated in our lab. The pmf of p28 and 
p35 from infected plasma also contained new peaks (FIG 3.4), suggesting that following 
infection, CRP-2 recruited new members to the interacting complex. These novel peaks 
did not match to proteins in the MSDB. However, their low m/z values (800-1000), 
suggest that the other 28 and 35 kDa protein partners are basic, containing multiple 
arginine/lysine residues which are susceptible to tryptic digestion.  
 Similarly, mass spectrometric analysis of CRP-1-interacting protein partners 
show that p70 matched to hemocyanin, and identified both p40 and p35 to be CLs.  
Mascot search using the pmf of CRP-1-interacting p28, however, matched two lectins 
from the Japanese horseshoe crab: Galactose-binding protein (GBP;AAF74773) and TL-
1 (P82151), GBP was previously identified as a serum lectin that binds the galactose 
residue of Sepharose CL-4B (5) and was considered an extracellular glycosylated isoform 
of the hemocyte lectin TL-1, with which it shares 67% homology. In addition, a 
prominent 50 kDa (p50) protein band present in the CRP-1 interacting profile (FIG 3.5A) 
was also analyzed by mass spectrometry. Surprisingly, the pmfs of p50 exactly matched 
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the subset of novel peaks in p28, suggesting that the novel CRP-1 interacting partner 
possibly exists as dimers.  
 To confirm the identity of the p28 lectin, the corresponding cDNA was cloned 
and characterized.  A full length clone of 940 bp, encoding 256 amino acids was isolated 
(FIG 3.5B).  Computational analysis of GBP predicted a signal peptide of 24 amino acids 
and a mature protein of 232 amino acids.  Hydrophobicity analysis indicates GBP is fully 
soluble. A Swissprot database search showed 96% homology to Tachypleus GBP and 
66% homology to TL-1.  The newly cloned gene from C. rotundicauda is thus named 
CrGBP (AY647278).  Earlier studies have reported the existence of multimers of GBP, 
which cannot be resolved on denaturing SDS-PAGE (Chen et al, 2001).  The 
mechanism(s) underlying GBP multimerisation is not well understood. However, work 
by our group suggests that GBP binding is dependent upon the action of serine proteases 
(Ng et al, unpublished data). The results indicate that both monomeric and a non-




3.1.4 Glycosylation primes CRP-2 for more efficient interaction with protein 
partners of the hemolymph 
Until recently, human CRP was thought to be non-glycosylated. It is now 
known, however, that human CRP is, in fact, glycosylated, and that this post-
translational modification takes on varied forms, depending on the nature of the 
pathogen involved (Das et al, 2003). The exact function of glycosylation is unknown, 
although infection-induced glycosylation strongly suggests a role in enhancing 
immune-related functions of CRP. Investigations into the functions of glycosylation, 
however, are hampered by the great variety of CRPs present in the horseshoe crab, and 
the limitations of current techniques to purify them. In order to clarify the potential 
function(s) of glycosylation in CRPs, we adopted use of recombinant proteins. We 
hypothesized that disconnecting CRP glycosylation from infection events would not 
significantly affect the ability of the end product to mimic native CRP functions. CRP-2 
contains a single predicted glycosylation site (Ser 7), as predicted by an algorithm 
scanning for eukaryotic glycosylation patterns (Gupta et al, manuscript in preparation).  
DNA coding for full-length CRP-2 was cloned into the yeast expression vector, pYEX. 
The resultant recombinant protein (gly-CRP-2) was similarly used for GST-pull down 
experiments with infected CFH proteins, in the presence and absence of divalent 
calcium ions.  
Pull down fractions resolved by SDS-PAGE suggests that glycosylated CRP-2 
did not depend on calcium for enhancement of interactions with plasma proteins (FIG 
3.6A). This was confirmed by densitometric analysis of the intensities of the interaction 
profiles (FIG 3.6B). The ability of gly-CRP-2 to interact more intensely than non-
glycosylated CRP-2, and to do so constitutively, independent of calcium, suggests that 
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this post-translational modification is geared towards increasing the efficiency of 
“pathogen-recognition complex” recruitment.  
MALDI-derived pmfs confirmed that gly-GST-CRP-2 interacts with other 
CRPs (p28) and CLs (p35), confirming that interactions with these protein partners 
were not dependent on the glycosylated condition of CRP-2. Surprisingly, the pmfs of 
p40 exactly matched a subset of the m/z peak values in the p70 pmf, confirming that it 
is both full-length and fragmented hemocyanin are recruited to glycosylated CRP-2.  
3.1.5 Conclusions 
 
Taken together, the results show that rCRPs interact with proteins of the naïve 
cell-free hemolymph (CFH). This naïve CRP-complex represents a pool of innate 
immune molecules that readily associate into a “pathogen-recognition complex” early 
in infection. The interactions of rCRPs are enhanced during infection and in the 
presence of calcium. 
CRP-2 oligomerizes with other CRPs, possibly to enhance avidity of CRPs to 
the pathogen surface. CLs possibly mimic the function of TLs, mediating bacterial 
agglutination as part of the overall antimicrobial activity of the “pathogen-recognition 
complex”. In contrast, CRP-1 interacts preferentially with GBP, a lectin which exhibits 
affinity for N-acetyl-containing ligands. The exact role of GBP in the complex is 
currently under investigation. It is postulated that the inclusion of more lectins in 
confers increased specificity to the “pathogen-recognition complex” to bind certain sets 
of PAMP arrays present on specific pathogens.   The results of GST pull down assays 
have been replicated in yeast-two-hybrid assays in our lab (unpublished data; work in 
progress), further strengthening the confidence level of our data. 
Recently, hCRP was reported to show diverse glycosylation patterns upon 
infection (Das et al, 2003). Pull down experiments show that glycosylated CRP-2 does 
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not depend on calcium for enhancement of interaction with other plasma proteins. By 
extrapolation, this suggests that glycosylation of hCRP primes it for recruitment of a 
similar “pathogen-recognition complex” during pathogen challenge, independent of 
calcium fluxes in vivo. It may well be that the glycosylated condition of horseshoe crab 
CRPs allow them to recruit complexes of innate immune molecules at constitutively 
high levels,  and is pivotal in mediating the powerful innate immune system in the 





















3.2 The antimicrobial properties of rCRP-2 
 
Thus far, the antimicrobial properties of human CRP (hCRP) appear to be 
mediated via the complement system and an enhanced humoral immune response. 
Whether hCRP exhibits antimicrobial activities on its own is unknown.  
In the Japanese horseshoe crab, Tachypleus tridentatus, it is known that CRP-2 
isotypes, collectively purified based on affinity to PEA (Iwaki et al, 1999) are able to 
agglutinate E. coli K1. The basis of this action, however, was explained to be affinity 
for sialic acid present in the bacterial membrane (Iwaki et al, 1999). Moreover, the use 
of isoprotein mixtures for the characterization of CRPs implies that the functional 
overlaps and convergences between isoforms cannot be clearly defined. 
In this study, we demonstrate that a single isoform of CRP-2 from the Singapore 
horseshoe crab, Carcinoscorpuis rotundicauda, exhibits antimicrobial activity. 
Specifically, a recombinant form of CRP-2 (rCRP-2) causes agglutination and is 
bactericidal towards Gram-negative microbes. Unlike plasma protein interactions, 
antimicrobial activity of CRP-2 is not dependent on external calcium concentrations, 
nor on glycosylation of the protein. Additionally, we demonstrate that rCRP-2 binds 
phosphorylcholine (PC) and Lipid A of the Gram-negative-specific PAMP, LPS. The 
latter result suggests that bactericidal effects of rCRP-2 are due to the protein’s ability 
to interact with hydrophobic elements of bacterial membranes, so causing disruptions in 
lipid bilayer continuity and compromising the integrity of the microbe. 
3.2.1 rCRP-2 exerts its antimicrobial effect on GNB 
 
 In order to determine whether CRP-2 posssess antimicrobial activity, 10 µM of 
recombinant CRP-2, purified from E. coli cell lysate, was separately incubated with     
1 x105 cfu / mL of P. aeruginosa, E. coli and S. aureus. 105 cfu is the range at which 
antibacterial assays are typically carried out. (Amsterdam, 1996). A high concentration 
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of protein was used, since this was a preliminary assay and the window of efficacy of 
rCRP-2 had not yet been established. The strategy was to begin with a large excess of 
the protein in the minimal amount of bacteria. If rCRP-2 exhibited antimicrobial 
activity, further work may then be done to determine the lowest effective concentration. 
On the other hand, lack of antimicrobial activity observed would not lead to doubts 
about whether an appropriate concentration of rCRP-2 had been selected. 
 rCRP-2 inhibited the growth of Gram-negative bacterial cultures. This 
bacteriostatic effect was observed as no increase in OD600 values following  three hours 
of incubation with CRP-2. In constrast, cultures of S. aureus, a Gram-positive bacterial 
species, did not exhibit this growth inhibition. The growth the culture which had been 
incubated CRP-2 closely mirrored that of a negative control that had contained no 
CRP-2 (FIG 3.7). 
The effects of rCRP-2 were confirmed by pull down of  whole CFH using 
bacterial beads ( Zhu et al, manuscript in progress). Hemolymph proteins that bind 
bacterial PAMPs were eluted and analyzed by SDS-PAGE and western blot with anti-
CRP antibodies. The results indicate that large amounts of native CRPs readily bind to 
PAMPs displayed on the surface of P. aeruginosa. In constrast, almost no CRPs 
interact with S. aureus, indicating that CRps are probably Gram-negative-specific PRRs 
(FIG 3.7C). Failure of rCRP-2 to bind Gram-positive-associated PAMPs is probably 
the reason for the Gram-negative specific effects of rCRP-2.  
3.2.2 Glycosylation does not enhance the antimicrobial effects of rCRP-2 
 
Glycosylation may considerably influence the physicochemical properties and 
function of a protein and is one of the most important post-translational modifications 
for deciphering protein function (Rudd et al, 2004). 
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Unlike their human counterpart, horseshoe crab CRPs are constitutively 
glycosylated (Iwaki et al, 1999), although the exact function of this glycosylation is 
unknown. Until recently, hCRP was assumed to be unglycosylated; it is now known 
however, that hCRP exhibits different patterns of glycosylation under different 
pathogenic conditions (Das et al, 2003).   
 Given the link between glycosylation and infection, it is pertinent to ask if 
glycosylated rCRP-2 would exhibit greater antimicrobial activity than the 
unglycosylated form. Surprisingly, the activites of glycosylated and unglycosylated 
rCRP-2 were not appreciably different, as determined by monitoring OD600 of P. 
aeruginosa cultures separately incubated with both forms of the protein (FIG 3.8). 
These findings suggest that glycosylation is not important for the function of CRPs per 
se but mediates critical protein-protein interactions amongst innate immune defense 
molecules of the CFH (see 3.1.4).   
 On a practical note, the yield of recombinant proteins from yeast is significantly 
lower than those from bacterial cells (TABLE 3.1). The ability to use rCRP-2 from 
bacterial sources for downstream investigations into the antimicrobial activity and 















FIG 3.7: Bacterial growth inhibition by rCRP-2. (A)Bacterial suspensions (105 cfu/ 
mL) were pipetted into ELISA plate wells and incubated with CRP-2. Bacterial growth 
was monitored by taking OD600 readings of each well. Growth is reflected as an 
increase in bacterial density, which results in increase of OD600. For each bacterial 
species tested, control cultures, with no CRP-2 added (red box), was included. (B) 
OD600 measurements were plotted as a function of time. Both P. aeruginosa (square) 
and E. coli (triangle) test cultures (black) did not grow in the presence of CRP-2, 
relative to controls (grey). Data points represent the mean values of three independent 
experiments and flags indicate standard deviation. (C) Pull down of  whole CFH using 
bacterial beads and western blot indicates that native CRP present in CFH do not 
interact with S. aureus. Failure of rCRP-2 to bind Gram-postive bacteria-associated 



































FIG 3.8: The antimicrobial activity of rCRP-2 was not dependent on glycosylation, 
as seen from densities of P. aeruginosa liquid cutures incubated separately with 








3.2.3 Growth inhibition was dependent on both bacterial load and rCRP 
concentrations 
To further determine the efficacy of rCRP-2 as an antimicrobial agent, varying 
concentrations of CRP-2 were mixed with different densities of E. coli and P. 
aeruginosa. Again, OD600 readings were taken from ELISA plate wells containing 
different combinations of rCRP-2 and bacteria. Growth of both species of Gram-
negative bacteria were similarly suppressed by CRP-2 (p< 0.05) and were charted as a 
percentage of control cultures 
The growth inhibition effects of rCRP-2 was reduced as its concentration 
decreased (FIG 3.9). Conversely, higher bacterial loads required higher concentrations 
of CRP-2 to inhibit their growth. 625 nM of rCRP-2 was effective in limiting growth at 
bacterial densities of  up to 107 cfu/ mL, but cultures with a starting concentration of 
109 cfu/ mL exhibited no reduction in growth. However, 2.5 µM of rCRP-2 was 
sufficient to restrict growth across a wide spectrum of bacterial densities from 105- 109 
cfu/ mL. FIG 3.9B is a schematic diagram depicting the  “window of efficacy” of 
rCRP-2 as an antimicrobial agent. The minimum concentration of CRP-2 necessay for 
antimicrobial activity is  ~400 nM, since 312 nM of rCRP-2 was ineffective in 











FIG 3.9: Growth inhibition effects were dependent on both bacterial load and 
rCRP-2 concentrations. (A)Both P. aeruginosa (left panel) and E. coli (right) were 
tested to confirm the growth inhibition effects of rCRP-2 and to establish (B) the 
window of efficacy of CRP-2. Data points represent the mean values of three 
independent experiments. Flags indicate standard deviation. The shaded area in (B) 
indicates concentrations of rCRP-2 that are effective in limiting growth at the range of 
























FIG 3.10: rCRP-2 exhibits bactericidal activity. (A)Residual colony counts reveal 
that CRP-2 is capable of reducing viable bacteria densities by 109-fold. This result was 
confirmed by (B) the Miles and Misra (1953) method of serial dilutions to monitor and 
visualize bacteria density. The results indicate that CRP-2 completely killed P. 









3.2.4 rCRP-2 exhibits potent bactericidal activity 
Bacterial growth is the net result of a dynamic interplay of factors, apparent 
only when the ability of the surviving bacterial population to propagate outweighs the 
extent of the antimicrobial effects of rCRP-2. Bacteriostasis, as measured by OD600, is 
therefore a poorly-defined state. No net change in bacterial density may be the result of 
rCRP-2 agglutinating bacterial cells and inhibiting replication, though not necessarily 
killing the bacteria population. At the other extreme, the protein may disrupt cell 
integrity and cause lysis, so that only fragments of the bacterial cell contribute to 
optical density readings. In order to ascertain the antimicrobial effects of rCRP-2, 
bacterial suspensions were serially diluted and plated on MHA (Becton Dickinson), 
following incubation with 2.5 µM of rCRP-2. Viable colony forming units (cfu) present 
in each bacteria suspension were counted following 18 hours of incubation at 37°C.    
rCRP-2 is capable of causing up to 109-fold reduction in bacterial density after 1 
h, indicating that rCRP-2 exhibits bactericidal activity. The results of residual colony 
counts were confirmed by the Miles and Misra plate count assay (FIG 3.10B). 
Visualization of bacterial densities following incubation with rCRP-2 confirms that it 
possesses bactericidal activity. This effect is potent and rCRP-2 can completely kill P. 
aeruginosa, at densities of 109 cfu/ mL, within 1 h.  
3.2.5 rCRP-2 exerts its antimicrobial effects via interactions with LPS 
 In our lab, CRP-2 was first identified as part of a repertoire of LPS-binding 
proteins (Ng et al, 2004). The observation that rCRP-2 acts only against Gram-negative 
bacteria (GNB) further suggests that it is perhaps exerting its antimicrobial effects via 
interaction with LPS, which is a GNB-specific PAMP. To study the mechanism of 
antimicrobial activity, LPS was used to block putative LPS-binding sites of rCRP-2. 
Salmonella minnesota rough mutant (Re 595) LPS (Sigma) was used in these 
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experiments. This strain of LPS consists of lipid A and 2-keto-3-deoxyoctonate (KDO) 
and represents the conserved, minimum functional unit of LPS (Raetz, 1990). The PC 
motif commonly found in some LPS molecules is replaced by PEA in S. minnesota 
LPS. This moiety retains that charged phosphate group that interacts with the calcium-
binding pocket of CRPs.  Following incubation at RT for 3 h, the mixtures were taken 
for antimicrobial activity assays with P. aeruginosa and E. coli. Bacteria were also 
incubated with CRP-2 dissolved in TBS as a negative control.  
 LPS-blocked rCRP-2 had its antimicrobial activity abolished. In particular, a 1:1 
ratio of LPS to rCRP-2 abolished antimicrobial activity completely. Increasing the LPS: 
rCRP-2 ratios did not enhance this blocking effect. On the contrary, mixtures 
containing 2:1 and 5:1 ratios of LPS to rCRP-2 did not abolish CRP-2 activity 
completely and some antimicrobial activity of rCRP-2 continued to manifest (FIG 3.11). 
The reasons for this slight inverse correlation between rCRP-2 and LPS concentrations 
are unclear. It is known, however, that S. minnesota Re595 LPS aggregates at the 
critical concentration of 4 µM (Aurell & Wistrom, 1998). Thus, at 2: 1 and 5:1 ratios, 
LPS occur in 5 µM and 7.5 µM concentrations and likely form multimeric clusters in 
the aqueous buffer. This arrangement decreases the “exposure” of the LPS molecules to 
rCRP-2 and thus reduces binding and blocking of CRP-2. The proportion of 
“unblocked” rCRP-2 appears to be greatest in 2: 1 ratios of LPS to CRP-2, whilst 
increasing the proportion of LPS (5:1) blocked rCRP-2 activity further. This 
phenomenon probably reflects the dynamic transitions of monomer-fragment-aggregate 
which LPS undergoes in aqueous phases (Aurell & Wistrom, 1998).  
CRPs are known to interact with LPS in a calcium dependent manner. In 
particular, the calcium-dependent interaction of CRP with the phosphorylcholine 
moiety LPS has been the main paradigm for CRP characterization. Further, rCRP-2 had 
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previously been identified as a LPS-binding protein (Ng et al, 2004). The interaction of 
CRP-2 with LPS is thus in agreement with literature and other experimental evidence.  
Taken together, the evidence suggests that CRP-2 is a PRR which recognizes 
and binds LPS. In doing so, rCRP-2 exerts antimicrobial effects specific to Gram-
negative pathogens. The proposition that a specific isoform of CRP is exerting 
antimicrobial effects on Gram-negative bacteria via LPS interactions is novel. 
3.2.6 rCRP-2 causes bacterial agglutination 
CRP-2 from the Japanese horseshoe crab, T. tridentatus (tCRP-2), is known to 
cause agglutination of human erythrocytes, as well as of E. coli K1. To test if CRP-2 
from Carcinoscorpius rotundicauda also possess this capability, bacterial agglutination 
was performed using live P. aeruginosa. rCRP-2 causes the formation of large bacterial 
aggregates (FIG 3.12). CrCRP-2 appears to be a highly potent agglutinating agent; the 
effects were observed almost instaneously.   
Human pentraxins derive their name from their ability to oligomerize and form 
pentameric suprastructures. In horseshoe crabs, CRPs form hexagonal annular 
structures (Iwaki et al, 1999). The ability of CRPs to interact with one another may 
explain for their bacterial agglutination ability, drawing bacterial cells together as they 
attempt to form pentameric complexes. Thus far, biochemical evidence appears to 
suggest that recognition and binding of sialic acid by tCRP-2 is the main mechanism 
behind agglutination (Iwaki et al, 1999). The LPS-blocking experiments, however, 
indicate that CRP-2 from C. rotundicauda is able to bind LPS. CRP-2-induced 
agglutination of P. aeruginosa may thus be mediated by its LPS-binding capability. 
Bacterial agglutination may very well form part of the antimicrobial mechanisms of 
rCRP-2 towards GNB. 
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3.2.7 The antimicrobial effect of rCRP-2 is PC- and Lipid A- but not calcium-
dependent 
 Since hCRP is known to interact with the PC-containing molecules such as LPS, 
in a calcium-dependent manner (Thompson et al, 1998; Iwanaga, 2002). Analysis of 
the primary sequence homology between rCRP-2 and hCRP reveals conservation of the 
calcium-binding pocket (FIG 3.13).  Thus, the interactions of CRP-2 with LPS—and by 
extension, the antimicrobial effects of this protein—are possibly calcium-dependent. To 
test this hypothesis, rCRP-2 protein solutions previously cleared of divalent ions by 
dialysis with EDTA were spiked with 10 mM calcium before being taken for 
antimicrobial assays against P. aeruginosa and E. coli. 
FIG 3.13 indicates that enhanced calcium levels do not increase the potency of 
CRP-2 as an antimicrobial agent. This suggests that rCRP-2 is a truly unique CRP 
isoform, one which does not require calcium to bind Gram-negative PAMPs. It is also 
possible that CRP-2 is exerting its effects by binding to other substructures of LPS 
besides PC, hence its calcium-independent activity.  
PC, KDO and Lipid A —the three core constituents of LPS—were then used to 
separately bind and, possibly, block rCRP-2 antimicrobial activity. In particular, PC 
was tested in the absence and presence of calcium to ascertain its affinity to CRP-2. 
OD600 readings taken one hour after incubation with blocked rCRP-2 indicate that PC 
binding to rCRP-2 is indeed necessary for antimicrobial activity, although calcium was 
not an absolute requirement. Interestingly, blocking by PC did not abolish antimicrobial 
activity completely, since the test culture grew at ~65% of control cultures without 
rCRP-2. This indicates that antimicrobial activity of rCRP-2 is mediated by interactions 
with other substructures of LPS as well. Surprisingly, blocking with Lipid A also 
inhibited the antimicrobial activity of rCRP-2, although to a lesser extend than blocking 
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with PC would. The results suggest that rCRP-2 also interacts with Lipid A. In 
retrospect, the aggregation of LPS would have led to the formation of micelle structures, 
with Lipid A clustered in the hydrophobic interior. This arrangement would have 
effectively sequestered Lipid A away from rCRP-2. Failure to block rCRP-2 at its Lipid 
A binding site would explain for the lower efficiency of LPS-blocking/ inhibition. The 
ability of rCRP-2 to bind a hydrophobic motif of LPS also suggests it is able to interact 
with hydrophobic elements of the bacterial membrane. This ability might account for 














FIG 3.11: CRP-2 exerts its antimicrobial effects via interactions with LPS. The 
graph shows that pre-incubating rCRP-2 with various molar ratios of LPS abolishes 
antimicrobial activity (above). This was confirmed by visualization of Pseudomonas 
cell densities (below) in (A) control cultures and in cultures where rCRP-2 had been 




FIG 3.12: CRP-2 causes agglutination of P. aeruginaosa. (A) Bacteria suspended in 
TBS did not agglutinate. In contrast, (B) 50 µg of CRP-2 causes visible bacterial 
agglutination. Both photomicrographs were taken at 400X magnification.  Clumped 




























FIG 3.13: Dissecting the interactions of rCRP-2 that are important for 
antimicrobial activity. (A) The antimicrobial activity of rCRP-2 on both P. 
aeruginosa and E. coli is not calcium-dependent, as seen from percentage growth 
measurements of bacteria cultured in the presence and absence of Ca2+. This was 
despite (B) conservation of the calcium-binding pocket human CRP (hCRP) and CRP-2. 
In human CRP, Asp60, Asn 61, Glu138, Gln 139, Asp140 and Glu 147 are responsible 
for binding calcium via electrostatic interactions. Asp53, Asn54, Gln137 and Asp139 
are conserved in CRP-2 (highlighted in red), whilst Glu138 and Glu 147 are substituted 
by Asp (highlighted in purple), so maintaining negatively-charged carboxyl groups for 
electrostatic interactions with calcium. (C) The binding of rCRP-2 to PC as part of its 
antimicrobial mechanism, albeit in a calcium-independent manner. Surprisingly, 
binding to Lipid A is also an integral part of CRP-2’s antimicrobial action, since rCRP-
2 blocked with Lipid A was less effective in suppressing bacterial growth. At least 




















3.2.8 The C-terminal α-helix of rCRP-2 is critical for its antimicrobial activity 
 In order to decipher the structural motifs within rCRP-2 that account for its 
antimicrobial activity, truncated rCRP-2 protein were expressed in E. coli. These 
represent progressive deletions of the protein from the N-terminal and are illustrated in 
FIG 3.14.  Testing the various forms of rCRP-2, with different degrees of deletions, for 
antimicrobial ability suggest that loss of N-terminal β-sheet motifs do not adversely 
affect antimicrobial activity. However, loss of the C-terminal α-helix renders rCRP-2 
ineffective as an inhibitor of Gram-negative bacterial growth.  
Additionally, pre-incubation of rCRP-2 with PC and/ or Lipid A reduces its 
antimicrobial activity (FIG 3.13C). This suggests that the PC and Lipid A that binds 
rCRP-2 prevents the protein from engaging the PC and Lipid A motifs present in the 
LPS of the P. aeruginosa tested.  
The results suggest that the α-helix is important in mediating interactions of 
CRP-2 with LPS. Additionally, blocking experiments suggest that CRP-2 must interact 
with PC and/ or Lipid A motifs of LPS in order to effect bacteria killing. Taken 
together, it is possible that the C-terminal α-helix of CRP-2 is the portion of the protein 







FIG 3.14: C-terminal α-helix of rCRP-2 is critical for antimicrobial activity (A) 
Progressive N-terminal deletions of rCRP-2 were generated. In silico secondary 
structural prediction confirms that deleted constructs (indicated in different shades of 
blue) lack some β-sheets. Loss of these motifs do not affect the antimicrobial activity of 
rCRP-2. (B) Monitoring liquid cultures of P. aeruginosa incubated with the various 
forms of rCRP-2 confirms that loss of β-sheet motifs do not affect the protein’s ability 











   The antimicrobial action of rCRP-2 is independent of both calcium levels and 
of intrinsic protein glycosylation. CRP-2 belongs to the pentraxin family of plasma 
proteins, which are characterized by their oligomeric assembly and calcium-dependent 
ligand binding (Shrive et al, 1999). While rCRP-2 possesses a calcium-binding site, 
this functions not in LPS-recognition, but in mediating interactions with protein 
partners of the CFH. Interestingly, blocking by PC does not completely block the 
antimicrobial activity of rCRP-2; blocking by Lipid A also causes reduction in the 
protein’s ability to limit Gram-negative bacterial growth (FIG 3.13C). Unlike other 
CRPs characterized thus far, this isoform of CRP-2 appears to binds LPS at two 
different sites and functions in a calcium-independent manner. The binding of rCRP-2 
to the PC and Lipid A motifs of LPS is part of an overall mechanism that results in 
Gram-negative bacterial agglutination and bactericidal effects. Deletion mutants of 
rCRP-2 continue to exhibit antimicrobial activity, as long as the C-terminal 
amphipathic α-helix was conserved, suggesting this motif to be absolutely essential for 





4.1 The horseshoe crab as a model of innate immunity 
Despite an appreciation for its importance, attempts to study innate immunity in 
humans have been hampered due to the interference of the adaptive immune system. 
Unlike the adverse effects of adaptive immunity, such as autoimmune diseases and 
allergies, human individuals rarely survive defects of their innate immune system.  
Because they do not possess adaptive immune mechanisms, invertebrates have 
become the default model to investigate innate immunity. In particular, the Drosophila 
has been studied extensively, with a large body of literature centered on elucidating 
functions of the Toll pathways (Lemaitre et al, 1996; Hashimoto et al, 1988; Anderson, 
2000). Homologues of these Toll-like receptors, with each member having different 
PAMP specificities, have been found in mammals. These findings have served to 
validate invertebrate models of innate immunity.   
 More recently, drawbacks of the Drosophila model have emerged. The fragile 
nature of the experimental subject, as well as the low tolerance of the species to 
bacterial challenge (D’Argenio et al, 2001) makes pathogen challenge in this organism 
difficult to study. Further, the low volume of hemolymph obtainable from each 
individual makes protein identification, isolation and purification problematic and 
laborious, making it difficult to verify gene function. The use of horseshoe crabs 
(Iwanaga et al, 1997) to elucidate innate immune mechanisms has several advantages. 
Evolutionarily, these organisms are closely related to Drosophila and should thus 
exhibit innate immune defenses similar to those already found. Secondly, their larger 
size allows increased blood volume and more abundant genetic material to be sampled 
from each individual. Thirdly, horseshoe crabs have proven to be tolerant to high doses 
of bacteria (Ng et al, 2003), perhaps again because a larger body houses a greater 
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repertoire of innate immune defense molecules that can be mobilized during pathogen 
invasions. On a more practical note, the chitinous shell that protects these animals 
makes them extremely hardy, and easily handled during experimental manipulations.  
4.2  Identification of CRP-interacting proteins from the plasma 
In order to identify members of the CRP interacting-complexes as fully as 
possible, neat hemolymph was introduced directly to sepharose immobilized with GST-
CRP fusion protein. Separate controls were established by incubating samples of 
hemolymph with the sepharose alone and with GST-bound sepharose, respectively.  
Furthermore, an excess volume of hemolymph was allowed to saturate the affinity 
resins overnight. This experimental approach is in contrast to work by other groups. For 
example, Chiou et al (2000) have attempted to isolate innate immune molecules from 
horseshoe crab hemolymph. The hemolymph samples were pre-cleared by passing it 
through tandemly arranged sepharose and sepharose-protein A, prior to sepharose LPS. 
It was difficult to ascertain if sepharose- and protein-A-binding proteins could interact 
with LPS. Similarly, pre-clearing the hemolymph for use in GST-pulldown assays 
would preclude the identification of galactose-binding protein (GBP) as the 
predominant CRP-1 interacting protein, since sepharose itself is a galactose containing 
matrix. 
Both CRP-1 and -2 interact LPS on Gram-negative bacteria (Ng et al, 2003), 
and with different plasma proteins (3.1.3). The ability of CRP-2 to form hetero- and 
homo-oligomers with other CRPs (FIG 3.4) serves to enhance avidity of CRPs to the 
PAMP-bearing surfaces and would increase the efficiency of pathogen-binding by CRP. 
In contrast, CRP-1 interacts preferentially with GBP (FIG 3.5), a lectin which exhibits 
affinity for N-acetyl-containing ligands (Harum et al, 1993). The exact role of GBP in 
the complex is currently under investigation. It is postulated that the inclusion of more 
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lectins—CRPs, CLs and GBP—confers increased specificity to the “pathogen-
recognition complex” to certain sets of PAMP arrays present on specific pathogens.    
CLs and hemocyanin appear to bind non-preferentially to both CRP-1 and -2. 
CLs possibly mimic the functions of their homologues, tachylectins (TLs), in binding 
carbohydrate motifs on PAMPs and mediating cellular agglutination (Gokukan et al, 
1999). The associations between CRPs and CLs suggest that the postulated “pathogen-
recognition complex” is geared towards frontline pathogen recognition and binding, as 
well as bacterial agglutination as an early pathogen-neutralization strategy.  
Hemocyanin is known principally to function as an oxygen-carrier. Its 
appearance in a immune-related complex suggests that it possibly plays a role in 
immune defense. The abundance of hemocyanin in CFH has long been known 
(Fahrenbach, 1970) and it is logical to envisage hemocyanin having other significant 
function(s) besides acting as an oxygen carrier. Indeed, hemocyanin from Limulus has 
already been demonstrated to exhibit phenol oxidase activity when induced by 
proteolytic enzymes and detergents such as SDS (Decker et al, 2001; Nellaippan & 
Sugumaran, 1996; Kairies et al, 2001).   This is necessary for melanization of 
pathogens and is a key innate immune defense mechanism (Kawabata & Nagai, 2000). 
Further, hemocyanins and phenol oxidases share a number of similarities. Both 
molecules use copper as a ligand and may be activated by chaotropic agents, detergents, 
or low pH values (Zlateva et al, 1996; Salvato et al, 1998). Structurally, the degree of 
similarity between the active sites of phenol oxidase and hemocyanin is supported by 
spectroscopic and crystallographic data (Decker et al, 1996; Kairies et al, 2001). In our 
group, Carcinoscorpius hemocyanin has been demonstrated to show phenol oxidase 
activity when induced by serine proteases isolated from bacterial or fungal pathogens 
(Jiang et al, manuscript in preparation). The sheer abundance of circulating 
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hemocyanin suggests that tight control must be maintained over its phenol oxidase 
activity in order to prevent auto-melanization of the blood. Recruitment and adhesion 
of hemocyanin to GNB-bound CRP may provide such regulation. Upon binding, 
hemocyanin may be cleaved by transiently-interacting proteases that, in turn, activate 
the melanization cascade. This process ensures this defense mechanism is only 
activated in the proximity of pathogens.   
CRP-1 and -2 therefore appear to play differential but overlapping roles in their 
recruitment of different effector proteins to eventually mediate downstream host 
immune responses such as agglutination and PPO activity. 
4.3 Glycosylation of CRP relieves its functional requirement for calcium 
during infection   
Both glycosylated and non-glycosylated CRPs were investigated in GST pull 
down assays to understand the effects of this post-translational modification on protein 
function. The interactions of unglycosylated CRP-1 and -2 are enhanced in the presence 
of calcium (3.1.2). This divalent ion is known to be involved in a wide range of host-
directed immune defense responses. For example, cytosolic calcium increases are 
crucial for expression of immune -related genes (Dolmetsch et al, 1998). In particular, 
both NF-κB and NFAT are ubiquitous transcription factors induced by calcium fluxes 
(Aifantis et al, 2001). Both proteins play varied roles in immunity, governing 
expression of cytokines, chemokines and other acute-phase proteins in health and in 
various disease states. Intracellular calcium also activates internally-directed calcium 
pumps to facilitate neutrophil chemotaxis to bacterial pathogens (Partida-Sanchez et al, 
2001), while high plasma calcium levels are necessary for monocyte chemotaxis to 
sites of tissue injury and/ or infections (Olszak et al, 2000).  
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The secondary structure of hCRP in the presence or absence of calcium has 
been investigated by infrared spectroscopy. hCRP exhibits significant calcium-
dependent conformational changes. In particular, exposure to calcium caused 
significant spectral shifts in regions identified to be β-sheets (Dong et al, 1994). The 
calcium-binding pocket of hCRP is known to occur at the distal end of the protein, in 
association with its putative PC-binding site (Thompson et al, 1998).  Further, hCRP is 
known to oligomerize via specific β-sheets at the periphery of the barrel-like globular 
structure. The calcium pocket is similarly conserved in horseshoe crab CRPs and it is 
envisioned that calcium binding triggers conformational changes in CRP-1 and -2. Such 
structural shifts would further expose peptide regions which potentially interact with 
CRPs and other plasma proteins, so allowing enhanced interactions. The more intensive 
recruitment of protein partners in the presence of calcium suggests that CRPs are 
designed to function complementarily and in tandem with other innate immune defense 
pathways which utilize calcium. 
Different pathogens exhibit calcium-dependent behaviours. For instance, 
Streptococcus pneumoniae uses calcium transport mechanisms to direct virulence 
pathways (Azoulay-Dupuis et al, 1998). Similarly, Yersinia pseudotuberculosis utilizes 
calcium to regulate production of YopE, a cytotoxin involved in countering host 
phagocytosis (Julio et al, 2002). Calcium sequestration/ withdrawal mechanisms in the 
host system are a critical part of immune defense. Bearing in mind the requirement for 
calcium by other defense pathways, calcium accessibility involves an intricate interplay 
of factors at the host-pathogen interface.  
GST pull down profiles of gly-CRP-2 show that glycosylation removes the 
calcium-dependent enhanced recruitment of the “pathogen-recognition complex” 
(3.1.4).  Molecularly, glycosylation may induce conformational shifts in the structure of 
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CRP that perpetually expose interacting β-sheets. Such changes may allow greater 
intensity of interactions, independent of plasma calcium oscillations. The results 
suggest that glycosylation is geared towards increasing the efficiency of “pathogen-
recognition complex” recruitment at a time when calcium sequestration/ withdrawal is 
necessary to limit pathogenicity. The ability of hCRP to modify its functional 
requirements during infection via glycosylation (Das et al, 2003) underscores its pivotal 
role as a frontline innate immune molecule. 
4.4 The antimicrobial action of CRP-2 
 
Binding of hCRP to PC, a motif in LPS, has been shown to be calcium-
dependent (Kaplan et al, 1977). Although the putative calcium binding site is conserved 
in CrCRP-2 (FIG 3.13B), its bactericidal activity does not appear to be dependent on 
calcium. This might suggest either (1) that CRP-2 is not exerting its antimicrobial effect 
by binding to LPS present on Gram-negative bacterial cell walls, or (2) that CRP-2 
does, in fact, interact with LPS in a calcium-independent manner. 
The first postulate is incorrect. Pre-incubation of CRP-2 with LPS from 
Salmonella minnesota Re595 abolishes its antimicrobial properties. LPS from this 
rough mutant strain of S. minnesota consists of Lipid A, KDO and PEA. The latter 
directly substitutes for PC and retains the charged phosphate group that the PC-binding 
site of hCRP recognizes. Blocking of activity by this “bare bone” LPS structure 
indicates that recognition and binding of LPS is a critical step in the antimicrobial 
mechanism of CRP-2 while it is also demonstrated here that PC blocks the 
antimicrobial activity of rCRP-2, with or without addition of the calcium (FIG3.13C).  
Further CRP-2 only exerts its bactericidal effect on Gram-negative bacteria, indicating 
that it recognizes a GNB-specific PAMP.  
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Previous work by our lab has shown that the binding of CrCRPs to LPS are 
calcium-independent. In experiments with an LPS-conjugated sepharose-based affinity 
column, CRPs were not eluted by EDTA, but disassociated from LPS in the presence of 
a chaotropic agent such as urea (Ng et al, 2004) Thus, CRP-2 probably binds the PC 
moiety of the LPS of P. aeruginosa and E. coli in a calcium-independent manner.  
The lack of an effect of calcium ions is not due to high pre-existing levels of 
ions in the Muller Hinton Broth (MHB) used for antibacterial assay.  The background 
level of calcium in this broth has been investigated by atomic absorption spectrometry 
and shown to be approximately 8.4 x 10-5 M (D’amato et al, 1974). Such levels are 
much lower than naturally-occurring levels which would be found in eukaryotic hosts. 
D’amato and co-workers (1974), have carried out similar antimicrobial studies 
on a number of antibiotics and have used MHB supplemented with 2 mM CaCl2, to 
mimic physiological concentrations of ion in the host. Instead of observing similar 
efficacy of the antibiotics tested, a spike in calcium concentrations actually caused an 
increase in the minimum inhibitory concentration (MIC) of antibiotics necessary to 
limit growth in the bacterial strains tested. This was not an isolated phenomenon. Work 
by other groups have also demonstrated that aminoglycosides become progressively 
less effective when defined media were spiked with increasing concentrations of 
calcium. In addition, the increase in MIC was most pronounced when tests were carried 
out with Pseudomonas. (Gilbert et al, 1971; Zimelis et al, 1973). A brief investigation 
into the mechanism of this increase showed that the antibiotics were not inactivated. 
Early studies have established that interaction of Ca2+ ions with the bacterial membrane 
is responsible for the bacteria becoming unsusceptible, although the exact mechanism 
of this resistance remains unknown (Zimelis et al, 1973).  
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It may be argued that manipulating the calcium concentrations caused a 
concurrent increase in resistance of the pathogen to rCRP-2 and the strength of binding 
of rCRP-2 to LPS. The result would thus be that rCRP-2 does not appear to exhibit an 
increase in antimicrobial activity in the presence of calcium. However, introducing 2 
mM of calcium to the bacterial culture increases the MIC of gentamicin by 16-fold and 
that of tetracycline by 4-fold (D’amato et al, 1975). In this series of experiments, 10 
mM of calcium was used. The expected increase in bacterial resistance is extrapolated 
to be ~60-fold. Even if rCRP-2 were interacting with LPS in a calcium-dependent 
manner, the binding activity of hCRP to PC in the absence of calcium is 60% of the 
maximal capacity (Lee et al, 2001); theoretically, additions of calcium ions would only 
reduce the MIC of CRP-2 down by 2-fold and is insufficient to account for the bacterial 
resistance.  
Pull down experiments have demonstrated that calcium enhances interaction 
between CRP-2 and protein partners of the cell free hemolymph (3.1.2). In the absence 
of CFH interacting partners, rCRP-2 may function simply as a chelator/ sequestering 
agent of calcium. This prevents absorption of the ion to the pathogen cell wall, so 
limiting the development of bacterial resistance. In exerting its antimicrobial effect, 
rCRP-2 appears to interact with Lipid A, suggesting that it is capable of binding and 
disrupting bacterial membranes, even as calcium is recruited to strengthen the pathogen.  
The binding of rCRP-2 to LPS is thus part of an overall mechanism that results in 





4.5 CRP-2-Lipid A interaction mirrors that of other molecules in the immune 
system   
One finding from this project is that a specific isoform of CRP-2 from the 
horseshoe crab binds LPS at the Lipid A moiety. Several other LPS-binding proteins 
are also known to bind LPS at Lipid A. In particular, LBP, CD14, limulus anti-LPS 
factor (LALF) and bactericidal/ permeability-increasing (BPI) protein all bind Lipid A 
(Tobias et al, 1989; Warren et al, 1992 & Marra et al, 1992). These interactions have 
been well-studied and -characterized, and we now have considerable insights into the 
common theme shared by these putative Lipid A-binding proteins (TABLE 4.1).  
Both LBP and membrane-bound CD14 are central to the innate immune defense 
system and respond to LPS and other bacterial products. BPI was first isolated by 
Weiss and co-workers from the azurophilic granules of rabbit neutrophiles (1978). BPI 
exhibits remarkable potency and specificity towards Gram-negative bacteria. It appears 
to exert its effects by interacting with the Lipid A moiety of LPs, although no data exist 
as to their stoichiometry. The X-ray crystallography structure of human BPI shows that 
the protein folds into symmetric halves (Beamer et al, 1997) with two functionally 
distinct domains: a potently antibacterial N-terminal and a C-terminal region which 
confers opsonic activity to BPI (Elsbach & Weiss, 1998). In contrast to the large sizes 
of BPI (55kDa), LBP (60kDa) and CD14 (55kDa), limulus anti-LPS factor (LALF) is a 
small basic protein found in the L-granules of horseshoe crab hemocytes and is released 
into the hemolymph upon detection of endotoxins (Tanaka et al, 1982). An amphipathic 
loop of LALF (residues 32-50) binds LPS (Hoess et al, 1993) and consists of an 
alternating series of positively charged and non-polar residues.  
Amphipathic domains appear to be the common motif across all four molecules. 
These amphipathic regions most likely interact with the similarly amphipathic Lipid A. 
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Perhaps unsurprisingly, inspection of the rCRP-2 sequence also unveils a similar 
amphipathic pattern of alternating residues. In particular, the C-terminal portion of the 
rCRP-2 α-helix (FIG 4.1) displays a hydrophobicity profile similar to the amphiphatic 
α-helix of cecropin, a known antimicrobial peptide (Lowenberger et al, 1999).  
Significantly, the helix is the only structural motif conserved across the active forms of 
truncated rCRP-2 (FIG 4.2), suggesting it to be critical for rCRP-2 antimicrobial 
activity.  This portion of the α-helix also contains 3 basic residues [Lys (K) and His 
(H)]. These are probably involved in electrostatic interactions with the charged 
phosphate head groups of Lipid A.  
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FIG 4.1: Amphipathic profile of the C-terminal portion of rCRP-2 α-helix. This 
pattern closely mirrors the α-helix of cecropin (insert), a known antimicrobial peptide. 
Significantly, the α-helix is the conserved motif common across the active forms of 
rCRP-2 (FIG 4.2) and suggests it is important in mediating the antimicrobial effects of 
the protein. 
 
The binding of rCRP-2 to the Lipid A motif of LPS further suggests that the 
protein exerts its antimicrobial effects by binding to, and disrupting hydrophobic 
elements of the bacterial membrane. Protein-membrane interactions at the lipid-water 
interface can be promoted by electrostatic forces or by surface-exposed aromatic and 
aliphatic residues (Wimley & White, 1996). Such a mechanism has already been 
demonstrated in several other proteins. In particular, pore-forming toxins (PFTs) are 
known to interact with lipid membranes. These bind membranes and elicit their toxic 
effects via oligomerisation and the formation of transmembrane pores (Rietschel et al, 
1992).  
Homology modeling of rCRP-2 reveals that it contains a C-terminal α-helix. 
This had been postulated to bind Lipid A, based on a characteristic amphipathic motif. 
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By inspection, rCRP-2 also contains aromatic residues that can potentially interact with 
membranes. These may be grouped into three distinct clusters: 
 Typ 33, Typ 49, Phe 47, Phe 61, Phe 68 and Phe 70 all occur within the 
β-jellyroll core. Their interactions with the external solvent environment, 
if any, would be limited. The side chain of Phe 146 extends from the 
interior of the β-jellyroll to the PC-/ calcium-binding pocket at the distal 
end of the globular structure. 
 Trp 34, Phe 35, Trp 91 and Phe 112 occur externally at the surface of the 
protein and their side chains cluster together adjacent to the C-terminal 
region of the α-helix.  
 Trp 98, Trp 101 and Trp 162 occur externally and cluster near the N-
terminal of the α-helix.  
The phenylalanine-tryptophan cluster near the C-terminal of the α-helix is 
tightly packed together and, on first evaluation, appears to be an excellent candidate to 
mediate membrane-lipid interaction. However, these side chains protrude from β-sheets 
that compose the barrel-like structure of rCRP-2. Progressive deletions of these motifs 
have not been shown to limit the antimicrobial activity of the protein. On the contrary, 
rCRP-2 with some β-sheets (and their accompanying aromatic residues) removed 
actually exhibit slightly enhanced antimicrobial activity (FIG 3.14). 
In the alternative tryptophan cluster, both Trp 98 and Trp 101 protrude 
extensively from the protein surface. More importantly, all three side chains originate 
from the peptide backbone near the C-terminal and are thus conserved in the rCRP-2 
deletion constructs. While Phe 146 is also conserved across the functional forms of 
rCRP-2, it is not clustered with other surface-exposed aromatic side chains. Further, 
site-directed mutagenesis of tyrosine residues with phenylalanine abolishes membrane 
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penetration by a known eukaryotic PFT, equnatoxinII (Hong et al, 2002). On its own, 
Phe 146 is unlikely to be involved in mediating protein-membrane interaction. Thus, 
Trp 98 and Trp 101 likely facilitate interaction of rCRP-2 with bacterial membrane. 
Additionally, the side chain of Trp 162 interacts with the N-terminal of the α-helix. 
This interface possibly serves to stabilize a peptide chain just downstream of the helix. 
The chain likely acts as a “hinge” to allow the helix to “flip” and insert itself into the 
membrane. The dynamic movements of the helix would probably be facilitated by 
conformational changes in the side chains of Trp 162 and other residues around the 
helix-β-sheet interface (FIG 4.2). 
4.6      Proposed model of CRP-2 function  
 
FIG 4.3 shows a model for the mechanism of CRP-2 activity. CRP-2 associates 
with GrNB. (1) The propensity for CRP-2 to oligomerize brings bound bacterial cells 
into close proximity with each other and serves to facilitate bacterial agglutination. 
Additionally, (2) monomeric rCRP-2s are able to associate with the bacterial membrane. 
This lipid-protein interaction is mediated by surface-exposed aromatic residues. In 
particular, the side chains of Trp 98 and and Trp 101 bind the bacterial membrane. (3) 
The α-helix of rCRP-2 is amphipathic and is capable of interacting with the similarly 
amphipathic Lipid A of LPS that is anchored in GNB membranes. In order to do so, the 
helix must “flip” itself over the β-jellyroll structure and insert itself into the membrane 
via destabilizing conformational changes around the peptide chain “hinge”. CRP-2, 
however, does not act in isolation. (4) In vitro pull down experiments show that it 
interacts with several protein partners in the hemolymph. These include carcinolectins 
(CLs), which are homologous to tachylectin-5s found in the Japanese horseshoe crab, 
and the oxygen carrier, hemocyanin. In the early phases of infection, interactions of the 
CRP-2 complex are calcium-dependent. Infection also triggers transcriptional up-
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regulation of CRP genes (Ng et al, manuscript in progress). (5)The newly-synthesized 
CRPs possibly undergo posttranslational modifications which facilitate (6) calcium-
independent assembly of the complex in the hemolymph.  This complex is temporally 
dynamic. 1 hpi, a 40kDa CL is exchanged for a cleaved hemocyanin fragment that 
participates in pro-phenol oxidase melanization. (7) Interactions of CRP-2 with protein 
partners might stabilize conformational changes which facilitate membrane disruption 








FIG 4.2: 3-dimensional representations of functional rCRP-2s. Models of (A) full-
length rCRP-2 and (B and C) truncated rCRP-2s, progressively deleted from the N-
terminal, show that the α-helix (green) is conserved across all 3 functional forms. 
Progressive deletions from the N-terminal remove β-sheets. Side-chain of aromatic 
residues are shown: Phe (pink), Tyr (yellow) and Trp (orange). The amphipathic region 
of the α-helix is boxed in red. The proposed peptide chain hinge and the Trp 98/ 101 

















































FIG 4.3: Model of CRP-2 activity. CRP-2 associates with Gram-negative bacteria 
(GNB). (1) CRP-2s oligomerize to bring bound bacterial cells into close proximity, 
facilitating bacterial agglutination. Additionally, (2) monomeric rCRP-2s associate with 
the bacterial membrane. This interaction is mediated by the side chains of Trp 98 and 
Trp 101. (3) The α-helix of rCRP-2 is amphipathic and is capable of interacting with 
the similarly amphipathic Lipid A that is anchored in GNB membranes. In order to do 
so, the helix must “flip” itself over and insert itself into the membrane via destabilizing 
conformational changes around the peptide chain “hinge”. CRP-2 does not act in 
isolation. (4) In vitro pull down experiments show that it interacts with several protein 
partners in the hemolymph. These include carcinolectins (CLs), which are homologous 
to TL-5s, and hemocyanin. In the early phases of infection, interactions of CRP-2 are 
calcium-dependent. Infection also triggers transcriptional up-regulation of CRP genes 
(5) Newly-synthesized CRPs possibly undergo posttranslational modifications which 
facilitate (6) calcium-independent assembly of the complex in the hemolymph.  The 
complex is temporally dynamic. 1 hpi, a 40kDa CL is exchanged for a cleaved 
hemocyanin fragment that participates in pathogen melanization. (7) Interactions of 
CRP-2 with protein partners might stabilize conformational changes which facilitate 







4.7 Concluding remarks 
 
While humans have a single type of CRP protein, the evolutionarily ancient 
horseshoe crab is known to possess a repertoire of CRP isoforms. Although these have 
been characterized biochemically into 3 groups of different isotypes, the function of 
individual CRP isoforms have not been studied. GST-pull down assays suggest that 
both CRP-1 and -2 interact with different plasma proteins under both naïve and infected 
conditions. The naïve CRP-complex represents a pool of innate immune molecules that 
readily associate into a “pathogen-recognition complex” during the early phases of 
pathogen challenge. This “pathogen-recognition complex” is temporally dynamic, 
suggesting that components are readily exchanged and recruited for more efficient 
activity against specific pathogens (Ng et al, manuscript in preparation). Individually, 
each member of the complex may mediate different downstream immune responses. 
Hemocyanin is postulated to be involved in prophenol-oxidase mediated melanization 
while CLs probably facilitate bacterial agglutinations (similar to the functions of TL 
homologues). While the function of CRP-1 is as yet unknown, its affinity for GBPs 
suggests that it functions in tandem with GBP to promote a versatile “pathogen-
recognition complex” capable of binding different PAMP arrays. 
Previous work suggested that CRP-2 isotypes possibly exhibit antimicrobial 
activity (Iwaki et al, 1999). In this work, a single CRP-2 isoform demonstrates bacterial 
agglutination and bactericidal activities, via the phosphorylethanolamine (PEA) and 
lipid A motifs of LPS. However, neither glycosylation nor calcium enhanced 
bactericidal activity, suggesting that these factors are not necessary for the 
antimicrobial properties of CRP per se but are important for recruitment of the 
“pathogen-recognition complex”, which consequently mediates bacterial clearance via 
other antimicrobial domain(s) of CRP-2. This is corroborated by our observation that 
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while CRP-2 is only effective against GNB, the “pathogen-recognition complex” 
mediated more rapid bacterial clearance than just CRP-2 alone (work in progress).  
4.8 Future perspectives 
 
The function of glycosylation in hCRP is unknown, although evidence points to 
a correlation between this post-translational modification and pathogen infections (Das 
et al, 2003). Using CRP-2 as a model, investigations by GST-pull down assays suggest 
that glycosylation is geared towards enhanced recruitment of a “pathogen-recognition 
complex” independent of calcium fluxes in vivo. Investigating the effects of 
glycosylations on CRP-1 and CRP-3 isoforms would serve to validate and extend 
current understanding of CRP and to enable more confident extrapolations of function 
to the single CRP in humans.   
 Current data suggests that the C-terminal α-helix of CRP-2 is pivotal to its 
bactericidal activity. In addition to the affinity of rCRP-2 for Lipid A of LPS, Trp 98 
and Trp 101 also facilitate the attachment of the protein onto bacterial membranes. Two 
experiments have been planned to verify the important of these motifs for the 
antimicrobial activity of rCRP2. 
 Firstly, truncated forms of rCRP- 2 that exhibit progressive deletions from the 
C-terminal would be generated. If the current postulation to the function of the 
C-terminal helix is correct, one would expect all forms of rCRP-2 lacking this 
structural motif to have its antimicrobial activity abolished. 
 Secondly, site-directed mutageneses that convert Trp 98 and Trp 101 to 
phenylalanine, or even glycine, would be carried out. Again, if postulations as 
to the function(s) of these residues are correct, one would expect mutated forms 
of rCRP-2 to exhibit much lower/ no efficacy towards GNB. 
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The long-term aim of rCRP-2 studies would be to develop a therapeutic peptide 
that targets the conserved PC/ PEA and/ or Lipid A of LPS so as to block the 
detrimental downstream effects of pathogen invasion. While current therapeutics 
employ polyclonal antibodies directed against LPS, the heterogeneous nature of LPS 
across species and serotypes make for variable protective effects (Opal & Gluck, 2003). 
Peptides derived from rCRP-2 would circumvent such inconsistency; instead of 
targeting variable O-antigenic regions of LPS, these would seek out the conserved core 
structure found in the basic LPS molecule. These peptides would thus be widely 
applicable against a broad spectrum of Gram-negative pathogens. 
 
